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As a group, the Neuronal ceroid lipofuscinoses (NCLs) form the most 
common inherited progressive childhood encephalopathies, with an 
incidence of between 1 and 5 per 100000 live births in different 
countries, while prevalence is estimated between 1 and 3 per million.1 
Accumulation of intracellular autofluorescent storage material and 
neurodegeneration are features of this heterogenous group of diseases, 
which lead to visual impairment, epilepsy, motor disorders and cognitive 
deterioration. 
Adult presentation is very uncommon, and knowledge of adult forms is 
very limited compared to the childhood forms. NCLs show recessive 
inheritance, except for the extremely uncommon autosomal dominant 
adult form, of which only a few families have been reported. This 
dominant adult NCL form is the subject of this thesis. 
The scanty literature on dominant adult NCL is reviewed below, but in 
this chapter we will also briefly review the knowledge of the different 
childhood NCLs and recessive adult NCL (Kufs’ disease), as a 
background to further chapters on the dominant adult form.
Several excellent monographs on NCL provide more detailed information 
on this topic2 3 4 5. 
Classification
Classically, distinction of different forms of NCL was based on age at 
onset6:
• infantile NCL (INCL , Hagberg-Santavuori disease or Haltia-
Santavuori disease)
• late infantile NCL (LINCL or Jansky- Bielschowsky disease)
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• juvenile NCL (JNCL , Spielmayer -Vogt or Batten-Mayou disease, 
which was first described by Stengel in 1826)!7
• adult NCL (ANCL or Kufs’ disease)
Later, identification of the ultrastructural morphology of the storage 
material added specificity to distinguish several forms: 
electron microscopy shows 
• granular osmiophilic deposits (GRODs) in INCL!9,
• curvilinear patterns in LINCL 10, 
• fingerprint profiles in JNCL 11, and 
• mixed patterns in ANCL.!12
Thus previously, NCL’s were categorized on the basis of age of onset, 
clinical course, and histopathology. Later the major classification system 
was based on genotype2, which will also be used in this chapter. 
Erroneously assuming that each clinical form was caused by a single 
genetic defect, gene labels CLN1 - 4 were assigned even before genetic 
defects were known. Now, of the presumed ten variants (CLN1-CLN10), 
eight genes have been identified, with more than 250 different 
mutations13. It is now clear that there is not always a one to one 
relationship between genotype and phenotype, e.g. CLN1 can present at 
all ages with varying clinical presentation14. Furthermore, great 
intrafamilial heterogeneity in mental or physical handicap is seen in 
JNCL15, which indicates multifactorial etiology. 
While the term Batten disease is still used frequently as a label to all 
NCL’s as a group , the use of eponyms like Hagberg-Haltia-Santavuori, 
Jansky-Bielschowsky, Batten-Spielmayer-Vogt-Sjögren, Kufs’ and Parry 
disease is discouraged and largely abandoned. In this thesis they are 
included for historical reasons, realizing that they do not represent 
uniform nosological entities, which is also true for labels like INCL or 
LINCL. Similar to other neurodegenerative diseases, depending on the 
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goal and principal focus of a clinician, pathologist, geneticist or 
researcher, this heterogenous group of diseases could be classified on 
age, symptoms and signs, genes, proteins (storage protein [e.g. SCMAS 
or saposins] or defective enzyme, either soluble or structural), histology 
or ultrastructure, or involved pathophysiological pathways like apoptosis 
or protein degradation. 
Persaud-Sawin et al indicate that the defective proteins in different NCL’s 
may interact along a single pathway. Their view is supported by the fact 
that most NCL variants manifest cell death and dysregulated 
sphingolipid metabolism, while several CLN proteins co-
immunoprecipitate, and because some CLN proteins correct disturbances 
caused by other CLN proteins (e.g. CLN2 protein corrects growth and 
apoptosis in CLN3-, CLN6-, and CLN8-deficient cell lines).16
We will now present a short review of all human NCL forms, using the 
genetic classification as an index.
CLN1
Infantile neuronal ceroid lipofuscinosis (INCL)
Hagberg-Santavuori disease or Haltia-Santavuori disease
MIM 256730
The infantile form of neuronal ceroid lipofuscinosis (INCL; CLN1) is the 
most severe and earliest onset form of NCL, starting around 1.5 years of 
age. Cardinal features are early developmental deterioration, retinal 
blindness, microcephaly, and seizures. INCL is caused by more than 50 
mutations in the CLN1 gene on chromosome 1p32. CLN1 defects may 
also present at later age. They cause deficiency of palmitoyl protein 
thioesterase 1 (PPT1), a lysosomal enzyme which removes fatty acids 
from fatty-acylated cysteine residues in proteins, which may also have 
Chapter 1
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other functions in axons and synapses. Accumulation of granular 
osmiophilic deposits (GRODS) which contain saposins A and D is seen in 
tissues, and abundant death of neocortical neurons occurs. 17 After 
Santavuori's 1973 description of INCL 18, most cases were reported from 
Scandinavia initially, but the disease occurs worldwide. 
Prospects for therapy include enzyme replacement, stem cell 
transplantation, gene therapy, and metabolic therapy aimed at depleting 
the abnormal substrate accumulation in the disease. 19
CLN2
Late infantile neuronal ceroid lipofuscinosis (LINCL)
Jansky- Bielschowsky disease
MIM 204500
Mutations in CLN2 on chromosome 11p15 which cause loss of tripeptidyl 
peptidase 1 (TPP1, a lysosomal exopeptidase that sequentially removes 
tripeptides from the N termini of polypeptides), lead to classic late-
infantile NCL (Jansky-Bielschowsky disease). More than 65 mutations 
are reported13. Electronmicroscopy of storage material shows curvilinear 
bodies, which are rich in subunit C of mitochondrial ATP synthase 
(SCMAS). LINCL usually has an onset between 1 and 5 years of age. 
Prevalence in the USA is around 200 children. 20 These children have 
progressive myoclonic seizures, ataxia, blindness and psychomotor 




Juvenile neuronal ceroid-lipofuscinosis (JNCL) or Batten/Spielmeyer-
Vogt-Sjögren disease 
MIM 204200
Batten disease (a name which is also confusingly used for all NCLs), or 
juvenile neuronal ceroid lipofuscinosis (JNCL), results from recessively 
inheriting mutations (48 known, most commonly a 1.02 kb deletion) in 
the CLN3 gene on chromosome 16p12.1, resulting in loss of battenin 
activity, deposition of mitochondrial ATP synthase subunit c, 
ultrastructural fingerprints and some curvilinear or rectilinear bodies in 
many cell types, and loss of CNS neurons. This disorder presents around 
the age of 5 years old with visual deficits, followed by seizures, cognitive 
impairment, motor deterioration (ataxia, myoclonus, gait problems, 
spasticity), hallucinations, and premature death by the third to fourth 
decade of life. 21 Because neurological symptoms often present years 
after occurrence of visual problems, JNCL should be considered in 
otherwise normal children presenting with visual loss with or without 
fundus changes like pigmentary/atrophic changes or a bull's eye 
maculopathy22. 
Interestingly, Cln3(-/-) mice have autoantibodies to GAD65 in their 
cerebrospinal fluid and elevated levels of brain bound immunoglobulin G 
(IgG). IgG deposition was also found within human JNCL autopsy 
material, and with increased age in Cln3(-/-) mice. Lim et al indicate 
early systemic immune dysregulation in Cln3(-/-) mice, which 




Autosomal recessive adult neuronal ceroid lipofuscinosis
AR-ANCL or Kufs’ disease
MIM 204300
CLN4 is the gene symbol for the adult form of NCL, but no genes have 
been identified yet. Individual or autosomal recessive cases are referred 
to as Kufs’ disease, while autosomal dominant adult NCL is also known 
as Parry disease. It is very unlikely that these 2 forms are caused by a 
single gene, which led some authors to suggest to use CLN5 for 
dominant ANCL24, but CLN5 was soon used as the genetic label for 
variant LINCL. Ever since, Kufs’ and Parry disease are usually lumped 
together under the CLN4 heading25. 
Adult NCL presents between 10 and 50 (or arguably 6526) years of age 
with epilepsy, ataxia, parkinsonism, myoclonus and cognitive decline and 
behavioral problems. In most cases no visual symptoms occur, and 
retinal pathology is usually absent. 
Berkovic et al. reviewed 118 cases published as Kufs' disease, but only 
50 cases fulfilled their diagnostic criteria, where fingerprint profiles or 
granular osmiophilic deposits by electron microscopy were considered 
mandatory for definitive diagnosis. Sixteen had inadequate data, 21 had 
a storage disease but not Kufs’, 10 had no neuronal storage, and 21 had 
atypical clinical features outside the spectrum of Kufs' disease. The 50 
accepted cases were separated into two clinical phenotypes: Type A with 
progressive myoclonus epilepsy, often with photosensitivity, dementia 
and movement disorders; Type B with dementia, motor disturbances 
and often facial myoclonus.27
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Autosomal dominant adult neuronal ceroid lipofuscinosis or Parry 
disease
MIM 162350
Autosomal dominant adult NCL (AD-ANCL) is reviewed more extensively 
because it is the subject of this thesis. AD-ANCL is very rare, with only 3 
American and 2 Spanish families reported apart from our Dutch family. 
Because of the scarce literature on AD-ANCL individual data of reported 
family members are summarized.
Boehme et al.28 described the first family (the ‘Parry’ family) with 
dominantly inheriting ANCL in 1971. They were living in southern New 
Jersey, but were from British descent. Four affected generations are 
reported, with details of all 6 affected members in generation IV only, 
but without medical information of previous generations. The pedigree 
indicates autosomal dominant inheritance. 
These 6 family members from the Parry family are described in more 
detail now:
IV-2 
He had an epileptic seizure preceded by seeing bright spots at the age of 
39, with cognitive problems, ataxia, weakness in the left arm, 
nystagmus, myoclonus and dysphasia. He also had ‘multicoloured 
scotomata’. Presence of a polyneuropathy was suggested by EMG, and 
later by absent tendon reflexes and wasting. EEG showed bilaterally 
synchronous spikes and sharp waves. He died at the age of 47. Autopsy 
showed cerebellar atrophy, with PAS-positive granular aggregates in 
neurons and astrocytes, cerebellar demyelination and loss of neurons. 
IV-3 
He had a first seizure at the age of 32. Cognitive deterioration with 
apraxia and dysgraphia, myoclonus, epilepsy and absent tendon reflexes 
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were seen. EEG showed bilaterally symmetrical spikes and waves. He 
died at the age of 42 years. Autopsy showed cerebellar and brainstem 
atrophy, distension of neuronal perikarya and proximal axons. 
Intraneuronal and glial autofluorescent PAS-positive storage material 
was abundant, with loss of neurons, e.g. in substantia nigra. 
Electronmicroscopy showed GRODs in neurons. [fig 11 and 12 in their 
paper shows GRODs in patient IV-3, very similar to findings in our AD-
ANCL family].
IV-5 
She had an epileptic seizure at age 30, shaking clumsy hands, 
progressive epilepsy, ataxia, severe action induced myoclonus, speech 
problems and mask face. EEG showed bilaterally rhythmic bursts. 
IV-7 
She had limited medical records, which mention clumsy hands at age 
32, epilepsy, myoclonus, ataxia and delusions. EEG was abnormal. She 
died at the age of 39 years old. 
IV-13 
At 31 years of age he had an epileptic seizure, followed by myoclonus, 
impaired speech, ataxia, decreased tendon reflexes in the legs. 
IV-15 
She had non-fluent speech at 33 years of age, and myoclonus. EEG 
showed paroxysms of sharp waves and spikes. 
Armstrong et al 29 later reported reduced leukocyte peroxidase activity 
in patients VI-13 and IV-15 of this Parry family.
Brodner et al.30 describe a not previously reported single patient from 
the Parry family, (age and description of his mother are compatible with 
Boehme’s case V2, which is also compatible with the pedigree as shown 
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by Leonberg in 198231) who presented at age 24 with epileptic seizures 
with loss of consciousness, preceded by seeing flashing bright lights. 
Angiography and skull x-ray showed a calcification of the left occipital 
lobe, where a cystic tumor was found during craniotomy, which was 
identified as a low-grade astrocytoma. Irregular electron dense bodies 
were found in a biopsy of occipital cortex, but also in tumor cells.
An update on this Parry family has been presented in 1982 by Leonberg 
et al31 , which confirms the early occurrence of seizures and myoclonus, 
followed by cerebellar signs, dementia, speech disorder and weakness in 
late stages. 
The second AD-ANCL family was reported in Spain by Ferrer et al.32, 
who describe cerebral biopsy findings in a single patient, from a family 
with 6 affected individuals. Their pedigree is shown in the paper, and 
some details of other family members were reported: disease onset was 
between 33 and 37 years of age; cognitive deterioration, facial 
dyskinesias and epilepsy occurred. In the single patient who was 
described in more detail, PAS-positive storage material was seen in 
pyramidal neurons. Ultrastructure showed GRODs. An EEG was normal. 
Badurska33 found cytoplasmic inclusions in lymphocytes of a father of 2 
children with late-infantile neuronal ceroid-lipofuscinosis (LINCL), who 
had had epilepsy since the age of 32. This interesting report is 
insufficient for a diagnosis of AD-ANCL.
Arpa34 presented a single case from a family with dominant ANCL at the 
1978 meeting of the Spanish Neurological Society, and later in a Spanish 
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report in 1991. Onset in this family was between age 31 and 48. 
Epilepsy, dementia, myoclonus, ataxia, dysarthria and pyramidal signs 
were seen. Ultrastructure showed GRODs in cortical neurons.
Josephson et al.35 report a large ANCL family of English ancestry, with 
10 affected persons in 5 generations, with autosomal dominant 
inheritance. The index patient presented at St Louis, USA, where one 
other family member was evaluated repeatedly, and 2 others only once. 
Histology was available from 3 patients, showing cortical atrophy, PAS 
positive storage material in neurons in many brain regions, while 
ultrastructure showed GRODs. These were also seen in sweat glands. 
Age of onset was between 32 and 40. Seven patients died at an age 
between 41 and 58. Seizures, dementia and movement disorders were 
common, but no retinal pathology was seen. 
Some patients were reported in more detail:
V-3 had an abnormal EEG before occurrence of cognitive decline, 
dyskinesias, dystonia, and hip girdle muscle weakness.
IV-1 had jerks dementia, mask face and seizures. 
IV-2 had seizures, memory loss, aphasia, mask face and myoclonus.
V-4 had jerks, chorea, dementia, myoclonus, seizures, hallucinations, 
and paroxysmal EEG activity 
V-5 presented with seizures, while an EEG showed spikes. Myoclonus 
and memory decline were reported.
VI-6 presented with a seizure, with epileptiform EEG. Myoclonus and 
cognitive deterioration were seen.




Burneo36 et al. report an adult NCL family with autosomal dominant 
inheritance from Alabama, with 9 affected individuals in 4 affected 
generations, while 3 other family members had a history of seizures. 
The initial symptom was often a tonic clonic seizure between ages 27 
and 29.
Patient B1 had a history of seizures.
C1, C2 and D1  had seizures, dementia and myoclonus.
E1 had seizures, dementia, myoclonus and parkinsonism.
E3, 4 ,5 and 6 all had seizures, dementia, myoclonus and parkinsonism.
F1 & F2 had seizures.
F4 Onset age was 30. He had dysarthria, tremor, myoclonus, ataxia, 
seizures and dementia. EEG showed generalized spike and slow wave 
discharges.
In patient E3, ultrastructure of PAS positive storage material in neurons 
showed GRODs, which were also found in the skin. 
Ivan37 et al. describe an African American woman with supposed 
dominant adult NCL. She, and her father had behavioral abnormalities, 
dementia and extrapyramidal signs, but no epilepsy. Fathers’ brother 
and her paternal grandfather also had behavioral changes and memory 
loss. Unlike the typical GRODs in other known dominant ANCL families, 
fingerprint profiles were the main findings on electron microscopy. 
However, ultrastructure was limited to skin biopsy only, which is 




vLINCL(Fin), Finnish late infantile variant NCL
MIM 256731
CLN5 is localized to chromosome 13q22, with 18 known mutations. 
Subunit c of the mitochondrial ATP synthase is the major protein in brain 
storage cytosomes, which also contain minor amounts of sphingolipid 
activator proteins (SAPs) A and D38. Electronmicroscopy shows 
fingerprints, curvilinear profiles, but also rectilinear complexes39. It 
usually presents at 3-7 years of age with motor clumsiness, followed by 
progressive visual failure, mental decline and later by myoclonus and 
seizures40. A more aggressively developing cognitive impairment has 
been described in a single family. 41 Occurrence outside Scandinavia is 
uncommon42, 43.
Three related patients from Colombia with a JNCL with fingerprint 
profiles, had a novel missense mutation in CLN5. CLN5 mutation may 
cause atypical late-onset neuronal ceroid lipofuscinosis, in addition to 
the late infantile form described in Finland.44
CLN6
variant Late Infantile/early juvenile NCL, ‘Indian vLINCL’ 
MIM 601780
The CLN6 gene on chromosome 15q23 is coding for an endoplasmatic 
reticulum resident transmembrane protein, which interacts with collapsin 
response mediator protein-2 (CRMP-2) that controls axon growth45. 
Defects are responsible for relatively rare NCL cases (some 80 reported 
families) that resemble LINCL clinically, presenting between 1 and 8 
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years of age with motor delay, dysarthria, ataxia and seizures. Visual 
failure can be the first symptom, but is sometimes absent. 
Electronmicroscopy shows not the expected curvilinear profiles, but 
fingerprint and rectilinear profiles. Initially found in India and in Czechs 
with a Roman Gypsy background, now more than 40 mutations were 
reported from nearly all continents. This gene is also responsible for NCL 
in Merino sheep and South Hampshire sheep46.
MFSD8/CLN7 
variant late infantile NCL
MIM 610951
CLN7 was initially used as a gene symbol for a presumed single gene 
behind a clinical variant LINCL form in Turkish patients47, 48, but the now 
known CLN7 mutations are not restricted to the Turkish population49. 
Furthermore, some Turkish LINCL cases are related to CLN650 or CLN8 
mutations51, thus ‘Turkish vLINCL’ is genetically heterogenous, caused 
by CLN 6, 7 and 8. 
With the identification of the MFSD8/CLN7 gene, in Turkish and Indian 
families52, it does explain a part of Turkish vLINCL, but is also seen in 
Italy53, Saudi Arabia54, and in an Egyptian family with clinical findings 






Mutations in the CLN8 gene cause Northern epilepsy (progressive 
epilepsy with mental retardation [EPMR], OMIM 600143) and a subset of 
Turkish variant late infantile NCL51. CLN8 is one of the TRAM-Lag1-CLN8 
proteins containing a Lag1 motif, which is involved in (dihydro)ceramide 
synthesis.56 Northern epilepsy is an autosomal recessive syndrome with 
tonic-clonic seizures, and onset at 5 to 10 years of age. While epilepsy 
decreases after puberty, mental retardation begins 2-5 years after the 
onset of seizures and continues through adulthood. The patients may 
reach 50 or 60 years of age. Curvilinear profiles and some granular 
components are seen ultrastructurally, containing subunit c of 
mitochondrial ATP synthase57. 
CLN9
MIM 609055
This is a putative gene, postulated to explain two Serbian sisters and 
two German brothers with a clinical history characteristic for juvenile 
NCL, but with curvilinear inclusions, fingerprint profiles, and granular 
osmiophilic deposits in neurons, lymphocytes, and conjunctival cells. 
Enzyme screening and sequencing of the coding regions of other NCL 
genes was negative. CLN9 is mainly studied in fibroblasts, which have a 
distinctive phenotype of rapid growth and increased apoptosis and 
diminished levels of ceramide, dihydroceramide, and sphingomyelin. 




congenital NCL, cathepsin D (CTSD) deficiency
MIM 610127
Only a few patients with this rare disorder have been reported, all with 
similar clinical and neuropathological findings. Cathepsin D is a 
lysosomal aspartic protease involved in protein degradation, but it may 
also regulate apoptosis58. The cathepsin D gene causes congenital NCL 
in sheep. In a patient of Pakistani origin, a nucleotide duplication,         
c.764dupA was found in the cathepsin D gene in homozygous form in 
the patient, and in heterozygous form in his father. It creates a 
premature stop codon, predicting a truncation of the protein. Cathepsin 
D deficiency mutations may underlie all cases of congenital NCL. 
Cathepsin D deficiency should be considered as a possible diagnosis in 
microcephalic neonates, who present with seizures at or before birth.59
In a prematurely born infant with microcephaly and hypertonia, a 
mutation in the cathepsin D gene was found60. He died after 2 days. 
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Autosomal Dominant Adult Neuronal 
Ceroid Lipofuscinosis: 












We describe a family with adult neuronal ceroid lipofuscinosis, with 
apparent autosomal dominant inheritance, observed in 6 affected 
individuals in three generations. Disease onset was usually in the fifth 
decade, but was earlier in the youngest generation. Early symptoms 
consisted of myoclonus in face and arms, epilepsy, auditory symptoms, 
cognitive decline, or depression. Parkinsonism occurred a few years after 
disease onset, with stooped posture, shuffling gait, bradykinesia, and 
mask face. Four subjects deteriorated to a state of severe handicap, 
with severe dementia, contractures, dysphagia, and dysarthria. Leg 
weakness evolved to flaccid paraparesis in 2 patients. Diagnosis was 
confirmed by brain biopsy in 1 patient and full autopsy in 2 patients. 
Abundant intraneuronal storage of autofluorescent material was found 
throughout the brain. Electron microscopy showed granular osmiophilic 
deposits and scarce fingerprint profiles. Striking loss of neurons in the 
substantia nigra pars compacta and reticulata was found. 123I-IBZM 
Single photon emission computed tomography in 2 patients showed loss 
of postsynaptic D2 receptor binding in the striatum. We conclude that 
parkinsonism in ANCL is likely to be caused by both presynaptic nigral 




The neuronal ceroid lipofuscinoses (NCLs, or Batten disease) form a 
group of progressive neurodegenerative diseases characterized by 
accumulation of autofluorescent pigment in neurons, with staining 
characteristics resembling ceroid and lipofuscin.1 While adult forms 
(ANCL) are extremely rare,2–4 infantile (INCL, Santavuori-Haltia 
disease), late-infantile (LINCL, Jansky-Bielschowsky disease), and 
juvenile forms (JNCL, Batten-Spielmeyer-Vogt disease) are the most 
common progressive neurodegenerative disorders in children. All 
childhood forms and variants are autosomal recessive disorders, 
clinically presenting with progressive visual loss, epilepsy, or cognitive 
impairment.1 Storage material has been shown to consist of the subunit 
c of mitochondrial ATP-synthase.5,6 However, in INCL, it is composed of 
sphingolipid activator proteins A and D (saposins).7 Phenotypic and 
genotypic heterogeneity led to a classification with 13 variants,8 in four 
age categories based on nine gene loci. While six genes are located, four 
genes are identified and more than 100 mutations are known.9 Adult 
neuronal ceroid lipofuscinosis was first described by Kufs in 1925,10 in a 
sibling pair with cognitive decline from ages 26 and 31 years with facial 
dyskinesias, gait disorder, and depressive delusions. Light microscopy 
showed ballooned ganglion cells with storage of yellow pigment 
throughout the brain. Since then, over 100 cases have been reported. 
While blindness occurs in childhood forms, visual symptoms are 
uncommon in ANCL. Although most cases are sporadic, family reports 
indicate both dominant (Parry disease) and recessive inheritance (Kufs’ 
disease). We present a Dutch family with autosomal dominant adult NCL 




The family pedigree is shown in Figure 1. Regional birth archives 
provided data about two earlier generations, but without signs of similar 
disease. The mother of Patient 1, together with 2 children, died at the 
age of 28 years of unknown cause. A summary of patient characteristics 
is given in Table 1. Other family members shown in the pedigree had no 
abnormalities in history, neurological examination, or 
electroencephalogram (EEG). 
Patient 1 
Before presenting at age 44 years with generalized tonic clonic seizures 
up to five times a day, this woman had complained of dullness of 
hearing, dizziness, and headaches for several years. After treatment for 
seizures, she remained bradyphrenic and apathetic. Over the course of 1 
year, she became demented, bed-ridden, and completely dependent for 
all daily activities. Facial expression was diminished. She was 
hypophonic and had myoclonic jerks. Several generalized seizures 
occurred each year. She became incontinent, and developed flexion 
contractures of the arms. Slight temporary improvement was seen after 
surgical release of a subdural hygroma. During this procedure, a biopsy 
of frontal cerebral cortex was obtained. Light microscopy showed 
ballooned ganglion cells with abundant autofluorescent and periodic 
acid–Schiff (PAS)-positive intraneuronal storage material. She died at 
age 51 years. 
Patient 2 
This daughter of Patient 1 had a first attack of jerks in both arms for 
several seconds without losing consciousness at the age of 46 years. 
She had to give up her job as a cashier due to increasing slowness, 
memory deficit, and cognitive decline. She was admitted after she was 
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found unconscious at home, followed by an episode with visual 
hallucinations for several days. Progressive myoclonus of the arms 
occurred and later also facial myoclonus. She complained of painful legs 
which sometimes buckled. Hearing and visual acuity decreased. Since 
age 47 years, she had decreased facial expression, progressive 
bradykinesia, rigidity, stooped posture, and slow, unstable, shuffling gait 
with hypokinesia of the arms and start hesitation. Treatment with 
levodopa (L-dopa) and bromocriptine was unsuccessful. 
Neuropsychological tests showed severe global cognitive deterioration, 
with deficits in spatial orientation, eye–hand coordination, divided 
attention, and word retrieval. EEG showed bilaterally synchronous 
epileptiform complexes. Computed tomography (CT) scan of the brain 
showed generalized atrophy. She was admitted to a nursing home at age 
53 years. She died at age 59 years of pneumonia. Autopsy was 
performed, showing PAS-positive intraneuronal storage material in 
neurons throughout the brain (Fig. 2). Electron microscopy showed 
extensive granular osmiophilic deposits, and sporadic fingerprint 
profiles. In the substantia nigra (both pars compacta and reticulata), 
severe cell loss was seen; only a few melanin-containing cells remained. 
Although uniformly affected by intraneuronal storage, the cell density of 
neurons seemed normal in most other areas (except cerebellar nuclei 
and oliva inferior). 
Patient 3 
In 1969, this sister of Patient 2 was referred at the age of 27 years for 
nervousness, vertigo, tinnitus, and deafness of the left ear. Neurological 
examination was normal except for bilateral perception deafness. After 
several depressive episodes, she developed generalized epileptic 
seizures at age 42 years, followed by a psychosis with hallucinations. 
Since age 45 years, she had progressive rigidity, shuffling gait, 
retropulsion, and decreased facial expression. Response to treatment 
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with L-dopa and bromocriptine was doubtful. She developed myoclonus 
of the arms, face, and tongue. Her condition progressively declined, with 
frequent generalized epileptic seizures, depressive episodes, and several 
psychotic episodes with visual hallucinations and delusions. From 1992, 
she was wheelchair-bound. Neuropsychological testing showed severe 
global cognitive impairment. CT scan and EEG were comparable with 
those of her sisters. She died at age 56 years of cardiac failure. Autopsy 
was performed with extensive intraneuronal storage ultrastructurally 
virtually identical to the findings in her sister. Here also, loss of melanin-
containing neurons in substantia nigra was extensive. Less severe 
neuronal cell loss was seen in cerebellar nuclei and oliva inferior. In 
cerebral and cerebellar cortex and basal ganglia, only intracellular 
storage was seen, without cellular degeneration. 
Patient 4 
This patient is a brother of Patients 2 and 3. He has had myoclonic jerks 
of the arms since the age of 36 years. He had progressive memory 
impairment. In a few years he became apathetic and bradyphrenic. He 
had infrequent generalized tonic clonic epileptic insults, several 
depressive episodes, and two episodes with visual hallucinations. From 
age 43 years, he developed progressive parkinsonian gait, hypokinesia, 
stooped posture, disturbed postural reflexes, facial myoclonus, mask 
face, and seborrhoea. His motorsymptoms and functional disability 
showed day-to-day fluctuations, worsening due to stress and fatigue. He 
had moderate hearing difficulty. Visual acuity bilaterally decreased to 
0.5. He often complained of painful legs. Strength of the leg muscles 
was retained, but tendon reflexes of the legs were absent. This now 55-
year-old man is severely handicapped. Again, CT and magnetic 
resonance imaging (MRI) scans showed cerebral and cerebellar atrophy. 
EEGs showed bilaterally synchronous epileptiform discharges. 123I-IBZM 
single proton emission computed tomography (SPECT) at the age of 54 
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years, using occipital uptake as a reference, showed decreased relative 
striatal uptake (right, 1.48; left, 1.37; reference, 1.89 ± 0.28; 2 S.D.), 
indicating loss of striatal D2 receptors (Fig. 3). 
Patient 5 
This now 37-year-old daughter of Patient 2 presented at age 24 years 
with a 5-year history of tension-type headache, migraine attacks without 
aura, and weight gain. Neurological examination was normal. However, 
EEG showed bilaterally synchronous epileptiform discharges, as were 
seen in other affected family members. At age 32 years, during her first 
pregnancy, she had myoclonus of the right arm. Since delivery, 
progressive myoclonus in both arms and chin occurred. Her muscles feel 
tight and she sometimes experiences a feeling of weakness in her legs. 
She has slight memory difficulties and sometimes slight dysarthria. 
Visual acuity is slightly decreased. Further neurological examination is 
normal and she is completely independent. Recently, she had a 
generalized tonic clonic seizure after delivery of her second child. 
Patient 6 
This now 35-year-old son of Patient 4 has had myoclonus of the thumb 
and arms from the age of 25 years. At that time, an EEG showed 
bilaterally synchronous epileptiform bursts, the typical pattern seen in 
affected family members. At age 31 years, he experienced attacks of 
loss of consciousness during several seconds. Two years later, he had a 
generalized tonic clonic seizure after heavy alcohol consumption. He had 
to stop working because of fatigue and a feeling of weakness in his legs. 
Climbing stairs became difficult. He has slightly decreased facial 
expression and slight hypokinesia, with continuous myoclonus of the 
right arm, but normal muscle strength. MRI scanning showed only 
moderate generalized atrophy. 123I-IBZM-SPECT showed a pattern in 
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accordance with decreased striatal D2 receptor binding (striatal/occipital 




With 6 observed affected patients in three generations, our study 
represents the second largest reported family with ANCL. It is the first 
study in which more than three affected patients were seen by a single 
observer. The vertical inheritance pattern in this family, via both male 
and female lines, strongly suggests an autosomal dominant inheritance. 
So far, two other families with autosomal dominant inheritance have 
been reported 9,12,13 but there are possibly nine families.14 Our family’s 
phenotype resembles the Parry family, as described by Boehme and 
colleagues,12 in many respects. As in our family, severe myoclonus 
(mainly in face and arms), cognitive decline, epileptic seizures, leg 
weakness, and decreased tendon reflexes in the late stage were seen in 
the Parry family. They also showed EEGs with bilaterally synchronous 
epileptiform bursts. Thus, it is very likely that these two families 
suffered from a single disease, possibly due to the same genetic defect. 
Little is mentioned in their patients about parkinsonism, but a mask face  
was reported in a single patient. Parkinsonism was a general feature in 
later stages of the disease in our family. Hypokinesia, rigidity, stooped 
posture, short-stepped gait, mask face and seborrhoea were prominent. 
While irregular trembling of hand and fingers occurred due to 
myoclonus, no tremor was seen. Treatment with L-dopa and 
bromocriptine was tried in 2 patients but had no effect. Autopsy clearly 
showed extensive neuronal cell loss in substantia nigra in both deceased 
patients. The contrasting absence of cellular degeneration in other brain 
areas points to a selective vulnerability of nigral cells. While the 
observed nigral cell loss could explain the parkinsonian features, the 
absent response to L-dopa and bromocriptine are suggestive of striatal 
dysfunction. Although IBZM SPECT was not available from the deceased 
patients, the clearly decreased striatal IBZM binding in Patients 4 and 6 
indicates striatal D2-receptor loss. Thus, the pathophysiology of 
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parkinsonism in this family is probably due to both pre- and 
postsynaptic nigrostriatal dysfunction. Clinical presentation is 
heterogeneous within our family. However, as shown in Table 1, 
myoclonus, dementia, parkinsonism, facial dyskinesias, and psychiatric 
symptoms all occurred within single individuals in later stages of the 
disease. In 1988, Berkovic and colleagues4 reviewed 118 reported cases 
published as Kufs’ disease, and revealed that only 50 cases fulfilling 
their histological criteria for this diagnosis were present: (1) fingerprint 
profiles (FP) or granular osmiophilic deposits (GROD); and (2) typical 
light microscopy. Possible or definite Kufs’ disease cases were divided 
into two types on prominence of clinical features: type A with seizures, 
myoclonus and neuropsychiatric symptoms (including dementia), 
sometimes with ataxia and dysarthria; and type B with dementia and 
motor abnormalities as the predominant features, with prominent 
cerebellar and extrapyramidal signs and facial dyskinesias. These two 
types were distinguished to serve as an aid for clinical recognition but do 
overlap. Although type B-like symptoms seem to occur later than type A 
symptoms in our family, separation of autosomal dominant ANCL in two 
types does not seem to be justified. As in previous reports of ANCL,15 
visual symptoms were scarce in contrast to childhood NCL, except for 
moderately decreased visual acuity and visual hallucinations. Auditory 
problems are not commonly reported in ANCL. However, tinnitus, 
vertigo, and hearing loss frequently occurred in this family. We assume 
they are part of the disease, related to the observed severe 
intraneuronal storage in brainstem and cerebellar nuclei. The 
combination of parkinsonism and facial myoclonus (possibly described as 
facial tics in early reports), especially with cognitive decline and 
bilaterally synchronous epileptiform complexes on EEG, are probably 
pathognomonic for ANCL. Further investigation of clinical, genetic, 
histological, and biochemical differences between adult types and 
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childhood NCLs may yield important clues to the still unknown 
pathophysiology of this devastating illness. 
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FIG. 1. Family pedigree (square, male; solid, affected). 
FIG. 2. Extensive intraneuronal storage is seen throughout the brain, with 
ballooned neurons and distended axon hillocks. Patient 2, pontine nuclei. 
Periodic acid–Schiff stain. Magnification, 440!. 
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FIG. 3. 123I-IBZM SPECT of Patient 4 shows decreased striatal uptake, 
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We describe the neuropathological and biochemical autopsy findings in 
three patients with autosomal dominant adult neuronal ceroid 
lipofuscinosis (ANCL, Parry type; MIM 162350), from a family with six 
affected individuals in three generations. Throughout the brain of these 
patients, there was abundant intraneuronal lysosomal storage of 
autofluorescent lipopigment granules. Striking loss of neurons in the 
substantia nigra was found. In contrast, little neuronal cell loss occurred 
in other cerebral areas, despite massive neuronal inclusions. Visceral 
storage was present in gut, liver, cardiomyocytes, skeletal muscle, and 
in the skin eccrine glands. The storage material showed highly variable 
immunoreactivity with antiserum against subunit c of mitochondrial ATP 
synthase, but uniform strong immunoreactivity for saposin D 
(sphingolipid activating protein D). Protein electrophoresis of isolated 
storage material revealed a major protein band of about 14 kDa, 
recognized in Western blotting by saposin D antiserum (but not subunit 
c of mitochondrial ATPase (SCMAS) antiserum). 
Electron microscopy showed ample intraneuronal granular osmiophilic 
deposits (GRODs), as occurs in CLN1 and congenital ovine NCL. These 
forms of NCL are caused by the deficiencies of palmitoyl protein 
thioesterase 1 and cathepsin D, respectively. However, activities of these 
enzymes were within normal range in our patients. Thus we propose 
that a gene distinct from the cathepsin D and CLN1-CLN8 genes is 




The neuronal ceroid lipofuscinoses (NCLs or Batten disease) represent a 
group of progressive neurodegenerative diseases with intraneuronal 
storage of autofluorescent lipopigment. NCLs have originally been 
classified in four major categories according to the age of onset: 
infantile , late-infantile , juvenile and adult forms [10]. A new 
classification based on phenotypic and genotypic heterogeneity 
distinguishes 13 variants. Six genes have been cloned (CLN 
1,2,3,5,6,8), and mutations in these genes have been identified. Two 
further genes (CLN4 and 7) have been postulated by exclusion of other 
genes [11;17]. Inheritance of childhood forms of NCL is autosomal 
recessive. The NCLs are the most common progressive 
neurodegenerative disorders in children, with visual loss, epilepsy and 
cognitive impairment. In adults, the common form of NCL is known as 
Kufs’ disease, which also has autosomal recessive inheritance. In 
addition, a very rare form of adult NCL with autosomal dominant 
inheritance (Parry disease; MIM 162350) has been described [16]. 
Genes associated with adult forms of NCL have not yet been 
characterized.
In all NCLs, loss of neurons and abundant intraneuronal autofluorescent 
lysosomal inclusions are seen. Ultrastructural patterns in NCL can be 
multiform [6]: in CLN3, CLN5 and CLN6 a mix of fingerprint profiles, 
rectilinear complexes and curvilinear profiles can be found in neurons. In 
CLN2 curvilinear profiles dominate, while CLN1 (caused by mutations in 
the palmitoyl protein thioesterase 1 or CLN1 gene ) is characterized by 
granular osmiophilic deposits (GRODs) [19]. In addition to CLN1, GRODs 
are found in congenital ovine NCL, caused by mutations in the cathepsin 
D gene[22], as well as in rare undefined types of NCL [3]. In CLN1 and 
congenital ovine NCL, GRODs are associated with storage of sphingolipid 
Chapter 3
50
activator proteins (SAPs, also called saposins) A and D. In most other 
NCLs the storage material largely consists of the subunit c of 
mitochondrial ATP-synthase (SCMAS) [7].
Recently, we described the clinical characteristics of a Dutch family with 
autosomal dominant adult NCL[18]. Here we report on the 
morphological, histochemical, and biochemical findings in autopsies of 




From the age of 44 this woman had progressive dementia, epilepsy, 
myoclonus and parkinsonism. A biopsy of frontal lobe cortex was taken 
in 1962.
Patient 2 (a daughter of patient 1) 
From the age of 46 she had myoclonus, cognitive decline, parkinsonism 
and epilepsy. She died at the age of 59 years.
Patient 3 (also a daughter of patient 1) 
This patient suffered from epilepsy, myoclonus, parkinsonism, 
depressions and progressive dementia from the age of 42 years, and 
died at the age of 56. 
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Patient 4 (a son of patient 1) 
This man had myoclonus from the age of 36 years, followed by cognitive  
decline, parkinsonism and epilepsy. He died at the age of 56.
Patient 5 (a daughter of patient 2) 
This patient had myoclonus and cognitive problems since a pregnancy at 
the age of 32. Several years before, bilaterally synchronous epileptiform 
discharges on electroencephalography (EEG) were seen.
Patient 6 (a son of patient 4 ) 
This man had myoclonus of the arms from the age of 25, epilepsy, 
parkinsonism and EEG features comparable to those of his niece (patient 
5).
Tissue material
Tissue material was available from three autopsies (patients 2, 3 and 4). 
Additional samples, including a brain biopsy sample (patient 1), a rectal 
biopsy samples (patient 3 and 4) and blood samples (patients 5 and 6) 
were obtained. All patients were clinically affected. 
Tissue from cerebral cortex (frontal, cingulate, temporal), hippocampus, 
striatum and globus pallidus, thalamus, hypothalamus, pituitary gland, 
mesencephalon, pons, medulla oblongata, cerebellum and spinal cord 
was systematically investigated. 
Histochemistry and immunohistochemistry
Brain and spinal cord were fixed in formalin for 6 weeks. Paraffin 
sections were stained for hematoxylin eosin (HE), Klüver-Barrera, 
periodic acid Schiff (PAS), Nissl, Gomori trichrome, Bodian, Congo red, 
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Sudan Black B, permanganate-aldehyde fuchsin sequence, and a 
modified Spielmayer technique as in previous reports [5].
Paraffin slides were also stained by monoclonal antibodies against glial 
fibrillary acidic protein (GFAP; BioGenex, San Ramon, USA), CD57 
(Leu-7, natural killer cells; Neomarkers, Fremont, USA), CD15 (Leu-M1; 
Becton Dickinson), CD68 (macrophages, Dako, Glostrup, Denmark), tau 
protein (microtubules; Sigma, St. Louis, USA), HLA-DR-DP-DQ (Dako), 
ubiquitin (Dako), synaptophysin (BioGenex), neural cell adhesion 
molecule (Zymed, San Francisco,USA), human neurofilament protein 
(Dako), neuron specific enolase (BioGenex), smooth muscle actin 
(BioGenex), human "-amyloid (Dako), Alzheimer precursor protein A4 
(Boehringer Mannheim Biochemica) and polyclonal antibodies against 
desmin (BioGenex). Cathepsin D (Dako, Copenhagen, Denmark) and 
subunit c of mitochondrial ATP synthase (SCMAS; a generous gift of 
prof. Eiko Kominami, Jutendo University, Tokyo, Japan) and sphingolipid 
activator protein D (SAP D, a generous gift of prof. Konrad Sandhoff, 
University of Bonn, Germany) were detected by polyclonal antibodies as 
described [5]. LSAB+ detection kit (DAKO) or Vectastain ABC detection 
kit (Vector Laboratories) were used for immunodetection. Electron 
microscopy was performed on cerebral cortex, pons, cerebellum, spinal 
cord, muscle, peripheral nerve and skin, as well as isolated storage 
material. Standard methods consisted of fixation in glutaraldehyde, 
post-fixation in osmium tetroxide, embedding in araldite and contrasting 
with uranyl acetate and lead citrate. A Philips CM10 electron microscope 
was used.
Enzyme activity assay
Assays of enzyme activity in leukocytes were carried out as described 
recently, for palmitoyl protein thioesterase (PPT1)[24], tripeptidyl 
peptidase 1 (TPP1) [28] and cathepsin D[20].
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Isolation of the storage material, electrophoresis and Western blotting
Frozen autopsy samples from the frontal, occipital and parietal cortices 
of patients 2,3 and 4 were pooled and storage material was isolated 
using CsCl centrifugations as described before[22]. The purity of the 
isolated storage cytosomes was confirmed by EM, and the protein 
content of the samples was measured according to Markwell et al.[15]. 
The storage material was analyzed by 17% SDS-polyacrylamide gels[13] 
and by Western blotting using antiserum against SAP D, kindly provided 
by prof. Konrad Sandhoff (University of Bonn, Germany), and against 
the mitochondrial ATP synthase subunit c, kindly provided by dr. David 





Myoclonus in face and arms, epilepsy, parkinsonism, dementia and 
personality changes were the cardinal clinical features in this family. 
Moderate visual symptoms and hearing loss occurred. Disease onset 
varied from 24 to 46 years of age. 
For detailed description of clinical characteristics see Nijssen PCG et al.
[18].
Macroscopy
The brain of patient 2 weighed 896 g, with severe global cerebral and 
cerebellar atrophy. The brain had a rubber-like consistency, and the 
substantia nigra was markedly depigmented. The brain of patient 3 
weighed 1012 g, with moderate frontal and cerebellar atrophy. The brain 
of patient 4 weighed 1144 g, with moderate global atrophy. Heart, 
intestines, liver, pancreas, kidneys and spine of all 3 patients were 
normal. Both women had normal female organs.
Light microscopy
Abundant storage of autofluorescent PAS-positive grains was seen in 
neurons throughout the central nervous system (fig 1A), but not in 
hypophysis, choroid plexus or dura mater. In some neurons individual 
grains of ceroid lipofuscin storage material were found; in other neurons 
more dense aggregates were seen. The nucleus was displaced by the 
lipopigment to the periphery, and ballooning of the perikaryon was seen. 
Some neurons, especially Purkinje cells, had a short, funnel-like 
broadening of proximal cell processes of axons, but probably also of 
dendrites. Neuronal density in cerebral cortex and basal ganglia was 
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slightly decreased, but the cytoarchitecture was normal (Prof. H. Braak, 
Frankfurt, Germany). Neuronal depletion was severe in substantia nigra 
(fig 1B) (which was depigmented in patient 3) and inferior olive, and 
moderate in cerebellar nuclei. Slight loss of Purkinje cells was seen in 
patient 2. The storage granules uniformly stained with permanganate-
aldehyde fuchsin sequence, and with Sudan Black B. There was no 
staining of the storage granules with the modified Spielmayer technique, 
except for occasional rudimentary deposits. No perikaryal spheroids of 
any type [5,8] were recorded. 
Immunohistochemistry
Increased GFAP and CD15 immunoreactivity was found in white matter, 
due to astrocytosis. HLA-DR-DP-DQ immunoreactivity was increased in 
striatum and globus pallidus, thalamus, N. ruber, arcuate nuclei, inferior 
olive and vestibular nuclei, suggesting increased activity of microglia 
cells. Neurons in cerebellar nuclei and sporadic substantia nigra neurons 
were labeled by tau antibodies. Diffuse ubiquitin reactivity in white 
matter, and sporadic ubiquitin labeling of neurons in substantia nigra 
and the arcuate nuclei was found. In Purkinje cells, the thickening of 
dendrites had neurofilament immunoreactivity. All neurons throughout 
the cerebrum stained strongly with SAP D antiserum (Fig 2 A-B), and 
also the astroglial cells showed positive signal. Further, the spinal cord 
was filled with SAP D-positive structures, which were, however, irregular 
in shape and thus represented either disrupted large neurons or, 
potentially, axonal enlargements filled with storage material. Most 
neurons displayed no staining for SCMAS, but some were strong or 
moderately stained.(Fig 2 C-D). Other markers were normal.
Visceral (non-neuronal) autofluorescent permanganate aldehyde fuchsin 
positive storage material was found in cardiocytes, skeletal muscle, liver 
(hepatocytes and occasional Kupffer cells), smooth muscle of gut, 
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peripheral nervous system of gut and in skin eccrine glands. Here, 
histochemical properties were similar to those in neurons. 
Electron microscopy 
Abundant compact granular osmiophilic deposits (GRODs) were found in 
neurons throughout the CNS (Fig. 3A). Their size varied from 0.5 to 2.5 
#m ø. Membrane-bound vacuoles were found in neurons, with 
polylobulated subunits, filled with GRODs and fat droplets ( 0.7 #m ø ) 
(fig. 3B and C). In spinal cord neurons the prevailing ultrastructure was 
GRODs, but also membrane covered ‘zebra body’ inclusions of 1 #m ø, 
containing parallel lamellar profiles, were observed. In glia cells, 
inclusions up to 4 #m ø were seen filled with numerous dense 
osmiophilic granules. Sporadic cell processes in cerebral cortex showed 
membrane-covered groupwise inclusions of fingerprint aggregates (fig. 
3D), sometimes associated with lipid droplets of <0.5 #m ø. No 
curvilinear or rectilinear complexes were found. 
In muscle, subsarcolemmal lipofuscin grains were found, composed of 
numerous lipid droplets (size up to 2 #m ø), and GRODs. However, few 
fingerprints were seen in smooth muscle cells of perimysial capillaries 
and in eccrine sweat glands in the skin, where many GRODs were seen 
with lipid droplets.
In a rectal biopsy of patient 3 at the age of 45, lipofuscin like inclusions 
were found in ganglion cells. Further, in a rectal biopsy from patient 4, 




Analysis of storage material
Storage cytosomes isolated from the pooled autopsy brain tissue of 
patients 2, 3 and 4 were brown in color and weakly autofluorescent, 
similar to storage material isolated from other forms of NCLs. Protein 
electrophoresis revealed a major protein band of about 14 kDa in 
molecular weight (Fig 4A). In addition, a double band of approximately 
40 kDa in molecular weight was detected, while no small molecular 
weight proteins were seen. In Western blotting the 14 kDa band was 
recognized by sphingolipid activator protein D antiserum (Fig 4B), while 
SCMAS was not detected. 
Enzyme activities
The activities of PPT1, TPP1, and cathepsin D, (the deficiencies of which 
are associated with CLN1, CLN2, and congenital ovine NCL respectively), 
were determined in patients 5 and 6. All activities measured from 
leukocytes of patients 5 and 6 were normal. PPT1 activities of patients 5 
and 6 were 59 nmol/h/mg and 34 nmol/h/mg (reference: 24-100 nmol/
h/mg), TPP1 activities were 290 nmol/h/mg and 216 nmol/h/mg 
(reference: 120-310 nmol/h/mg). Cathepsin D activity in fibroblasts of 




The neuropathological, electron microscopical and biochemical findings 
in our family unequivocally point to a diagnosis of adult neuronal ceroid 
lipofuscinosis. The pedigree of this family (fig. 5) indicates an autosomal 
dominant inheritance pattern. Dominant adult NCL has until recently 
been described in only two other families[2, 9, 14], and suspected in a 
few additional isolated cases and small families [1;4]. There was a 
striking clinical similarity between our family and the Parry family, as 
discussed before [18]. Recently, a new family with autosomal dominant 
adult NCL was reported by Josephson et al. [12]. Comparison of the 
Parry and Josephson families with our family strongly suggests that 
these patients suffer from a single disease: the light microscopical and 
ultrastructural findings are virtually identical, and clinical presentation is 
very similar. 
In the Parry and Josephson families, the EM pattern was dominated by 
GRODs, and no fingerprints or curvilinear profiles were found. Although 
some scarce fingerprints were seen in our family (especially in glial 
cells), ultrastructure of tissue of our patients was also dominated by 
intraneuronal and glial GRODs. As in the Parry family [2], severe loss of 
neurons was seen in the substantia nigra, which correlates with the 
occurrence of parkinsonism in our patients. However, previously 
reported SPECT studies also indicated striatal D2 receptor loss [18]. 
Thus, parkinsonism in our family can be attributed to both nigral and 
striatal degeneration. Neuronal cell loss was strikingly absent in certain 
areas, like pontine nuclei, despite abundant intraneuronal inclusions. 
The role of intraneuronal inclusions in the pathophysiology of 
neurodegenerative diseases has recently been the subject of discussion 
[26;27]. The relation between neuronal storage and cell loss is unclear 
in our patients. Regional differences may indicate independence of 
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neuronal degeneration and the storage process, but it is possible that 
cell death has occurred as a consequence of inclusion storage.
SCMAS is stored uniformly only in CLN2, where it has been suggested to 
be the substrate of the deficient TPP1 [7]. In CLN 3, 5 and 6 SCMAS 
storage is generalized, missing only in certain visceral storage sites [7]. 
In typical CLN1, histochemical SCMAS reactivity is almost absent, found 
only in some restricted neurons [7]. In all forms of NCLs, the storage 
material is strongly immunoreactive for SAPs, although SAP A and D are 
the major storage proteins only in CLN1, congenital ovine NCL and in 
Schnauzer NCL [21, 22, 23]. In our family, the participation of SCMAS in 
the storage process was also limited, and restricted to a subpopulation 
of neurons, while storage of SAPs appeared to be relatively uniform 
throughout the brain. Thus, immunohistochemically this family 
represented either a SAP storage disease or a mixture of SAP and 
SCMAS storage. Accumulation of SAP D was also confirmed by Western 
blotting from isolated storage cytosomes, which, however, did not 
contain SCMAS. 
Based on the ultrastructural, immunohistochemical and storage 
cytosome analyses, the disease of the present family resembles CLN1 
and congenital ovine NCL, which are caused by deficiencies of PPT1 and 
cathepsin D, respectively. Recently, an adult variant of PPT1 deficiency, 
characterized by GRODs and recessive inheritance, was described in a 
French family[25]. In the present family, however, the activities of PPT1 
and cathepsin D, were normal, excluding them as the cause of the 
disease. In addition, CLN2 has been excluded as the etiological factor by 
normal TPP1 enzyme activity. Other NCLs, such as CLN 3, 5, 6, 8 and 
Kufs’ disease have been indirectly excluded by the different clinical 
presentation, ultrastructure, immunohistochemical and biochemical 
findings, as well as by the dominant inheritance. In addition to the 
above-discussed forms of NCL, GRODs have been reported in two 
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genetically undefined NCLs: the congenital human NCL and adult 
Schnauzer NCL. The immunohistochemical characteristics of the 
congenital human (Tyynelä, unpublished data) and the adult Schnauzer 
NCL resemble those described here [23].
Therefore, it is likely that the gene underlying the presented form of 
autosomal dominant adult NCL is different from the identified NCL genes 
as well as from the (undiscovered) Kufs gene. Further genetic and 




Fig 1 Light microscopy of paraffin embedded tissue sections from 
patients with adult NCL. 
1A Periodic-acid Schiff (PAS) staining of pontine nuclei, showing intraneuronal 
storage of PAS-positive material, with ballooning of axon hillocks. 
1B In substantia nigra, severe loss of neurons was seen. (Bodian stain).  
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Fig 2 Immunohistochemical staining of paraffin embedded tissue sections from 
patients with ANCL. Bars, 20 µmeter.
A (top left) Sphingolipid activator protein D (SAP D) antiserum strongly stained 
the neurons throughout the cerebral cortex. Also the glial cells close to the 
surface of the cortex show positive staining for SAP D. 
B (top right) At higher magnification, the neurons showed pronounced 
accumulation of SAP D-positive storage material. 
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C (middle left)In contrast, antiserum against subunit c of the mitochondrial ATP 
synthase (SCMAS) stained selected neurons in the cerebral cortex (arrows). 
D (middle right) At higher magnification, one neuron in the deeper cortical 
layers shows strong positive staining for SCMAS whereas the neighbouring 
neurons are negative or mildly stained. 
E (bottom left) and F (bottom right) In control experiments (where primary 




Fig. 3 Electron micrographs of autopsy brain material from patients with 
adult NCL. 
3A Patient 3, cerebral cortex. Electron micrograph of a ballooned neuronal 
perikaryon showing massive storage of electron dense granular inclusions with 
lipid droplets. Magnification x 6075. 
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3B Patient 2. Neuronal storage in a cerebellar Purkinje cell: polylobulated 




3C Patient 2. Neuronal storage in cerebral cortex: polyglobular subunits filled 
with GROD in clear vacuoles. Magnification x 31500.
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3D Patient 2. Electronmicrograph of a neuronal process containing abundant 
membrane-bounded granular storage, electrondense fingerprints and lipid 
droplets. Magnification x 78750
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Fig 4A 17% SDS-PAGE of brain storage material isolated from patients with adult 
NCL .
The isolated storage material (10 [left] and 20 µg [right] of protein per lane) 
showed a major protein band of 12-14 kDa in molecular weight in silver stain. 
Molecular weight markers are shown on the left.
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Fig 4B Western blotting of isolated brain storage material using anti-SAP D 
antiserum. 
The major 12-14 kDa protein band of isolated storage material reacts strongly 
with SAP D antiserum (lanes ‘adult NCL’, 10 [left] and 20 µg [right]). Purified 
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Objective: to identify the genetic defect in a family with autosomal 
dominant adult neuronal ceroid lipofuscinosis. 
Methods: We applied genome wide STR-based linkage analysis to a 
Dutch multigenerational family with autosomal dominant ANCL, and 
performed subsequent fine-mapping of candidate loci.
Results: Under an autosomal dominant model 8 loci were suggestive for 
linkage with a LOD-score > 1. Three of these loci were most promising: 
two subsequent markers gave a LOD-score above 1 (on chr. 2 and chr. 
21) ; multipoint LOD-score calculations achieved a maximum score of 
1.96 on chr. 12. These 3 loci were further analyzed by genotyping with 
additional STR markers in the region. In the 3 loci a disease haplotype 
appeared to segregate with the disease. Markers in the proximity of the 
known NCL loci (1p32, 11p15, 16p12.1, 13q21, 15q21-33, 8p23, 
11p15.5) were checked, but none passed a LOD-score value of 1.
Conclusion: linkage analysis in this small family with autosomal 
dominant ANCL identified 3 genetic loci which segregate with the 




Although the gene symbol CLN4 has been assigned to adult NCL, no 
genetic defects are known in adult forms as yet. Unlike childhood NCL 
forms which are inherited in an autosomal recessive mode 1-3, the 
genetic defects in adult NCL are most likely heterogeneous: adult NCL 
occurs sporadic or familial with recessive inheritance (Kufs’ disease), 
but also with an autosomal dominant mode of inheritance in some 
families, called Parry disease 4 5 6 7 8 9. 
Our Dutch dominant ANCL family has been the subject of previous 
reports, concerning clinical 8, pathological 10, neurophysiological 11, 
auditory (chapter 6) and visual aspects (chapter 7).  
Here we report on genome-wide linkage analysis of this family.  
Methods and patients
We analysed a multigenerational family with autosomal dominant 
ANCL, with 6 known affected individuals in 3 generations. Blood 
samples for DNA extraction were obtained from 22 individuals 
including 5 patients, 13 healthy at risk individuals and 4 spouses. The 
family pedigree is shown in fig.1 . Genome-wide linkage analysis was 
performed, using 400 STR markers, with an average distance of 8 cM, 
and with subsequent fine-mapping of candidate loci.
Family characteristics: 
Patient 1
This woman with generalized tonic clonic seizures from the age of 44 
years, had progressive cognitive decline, myoclonus and 




This woman is a daughter of patient 1. She had myoclonus of arms 
and face from the age of 46 years, followed by progressive dementia, 
parkinsonism, generalized tonic clonic seizures and psychotic 
episodes. She died at the age of 59 years. 
Patient 3 
This sister of patient 2 had several depressive episodes, and 
developed generalized epileptic seizures at the age of 42 years, 
followed by psychotic episodes, parkinsonism, myoclonus and 
progressive dementia. She died at the age of 56 years.
Patient 4 
This brother of patients 2 and 3 had myoclonic jerks of the arms 
since the age of 36 years. He had progressive memory impairment, 
depressive episodes, parkinsonism, facial dyskinesias and generalized 
tonic clonic epileptic insults. He died at the age of 56 years. 
Patient 5
This daughter of patient 2 had tension-type headache and migraine 
attacks without aura from the age of 19 years. Since the age of 32, 
she has had progressive myoclonus and slight memory difficulties, 
and epilepsy. 
Patient 6
This son of patient 4 has had myoclonus of the thumb and arms from 
the age of 25, and frequent tonic clonic seizures since age 31. He has 




A genome-wide scan was performed by use of multiplex mapping 
panel of 400 autosomal STR markers with an average inter-marker 
distance of 8 cM. 
Genomic DNA was PCR amplified in 26 multiplex reactions using 
fluorescently labeled primers. PCR products were resolved on an 
ABI3730 automated sequencer (Applied Biosystems). Genotypes 
were assigned using in-house developed genotyping software.
Two-point and multi-point LOD-scores were calculated using MLINK 
and LINKMAP from the LINKAGE software package version 5.2 
(Lathrop et al. 1985). We assumed an autosomal dominant 
inheritance model with reduced age-dependent penetrance for the 
trait locus. The estimated population frequency of the disease gene 
was set at 0.00001. Nine liability classes for disease penetrance were 
used, based on the cumulative risk curve calculated from the mean 
onset age for ANCL in the family, with a maximal disease penetrance 
of 100% when $ 60 years. Phenocopy rates were also age-
dependent.
Results
Genome-wide STR-based linkage analysis
In an 8 cM density genome-wide scan, we calculated 2-point LOD-
scores $ 1 for 10 STR markers in 8 distinct chromosomal regions 
(table 1). On chromosomes 2 and 21 two subsequent markers 
achieved a 2-point LOD-score above $ 1. A maximum 2-point LOD-
score of 1.647 was reached at the chromosome 21. Multipoint linkage 
analysis of the 8 loci resulted in a maximum score of 1.731, for the 
chromosome 12 locus. Markers in the proximity of the known NCL loci 
(1p32, 11p15, 16p12.1, 13q21, 15q21-33, 8p23, 11p15.5) were 
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checked but none passed a LOD-score value of 1. Three loci were 
prioritized for further examination. The loci on chromosomes 2 and 
21 were selected because two subsequent markers showed 
suggestive linkage, and the chromosome 12 locus was selected 
because of the maximum multipoint LOD-score. Additional STR 
markers were selected for genotyping to achieve a marker density of 
about 1 STR/1 cM/locus.
Fine mapping of candidate loci and sequencing of positional 
candidate genes
Chromosome 12
For the markers included in the genome-wide scan a maximum 
multipoint LOD-score of 1.731 was obtained on chromosome 12 at 
D12S1056 . Twenty-two additional STR markers in the region 
covering 25 MB were used for genotyping in our family. LOD score 
calculations achieved a new maximum of 1.962 for 4 markers in the 
region (Table 2). Segregation analysis defined a risk-haplotype that 
appeared to segregate with the disease in the family. All patients 
were carrier of the risk-haplotype and meiotic recombination events 
in one patient deliniated the candidate region to a 13.11Mb region 
flanked by markers D12S1655 and GATA194G07. However, the entire 
risk-haplotype was also observed in one at risk individual. A small 
part of the risk haplotype at the telomeric end was also present in an 
individual who has just a 1% probably to still become ill, while 
meiotic recombination finemaps a priority region from D12S1655 till 
D12S375.
The potential candidate region on chromosome 12q14-21 contains 95 
known genes. Of these, 3 positional candidate genes, FAM19A2 
(coding for a gene product which is postulated to function as a brain-
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specific chemokine), GNS (glucosamine (N-acetyl)-6-sulfatase) , LYZ 
(lysozyme), were subjected to mutation analysis but did not reveal 
any mutations that could explain the disease in this family. 
Chromosome 2
Two of the 27 markers tested on chromosome 2 gave a 2-point LOD-
score above 1. At two subsequent markers, D2S1360 and D2S144, a 
LOD-score of 1.332 was calculated. Multi-point LOD-score analyses at 
this locus achieved a maximum score of 1.333. Following the 
genome-scan results, 8 additional STR markers were typed for 
segregation analyses. A minimal risk haplotype of 14.6 Mb was 
defined in a patient by two meiotic recombinants. The risk haplotype 
was present in all patients but also in two at risk sibs and one more 
relative. 
Chromosome 21
In the genome-wide scan the highest 2-point LOD score of 1.647 was 
achieved at marker D21S1893. The adjacent marker D21S1440 also 
reached a LOD-score above 1.
Four additional STR markers were genotyped in this region yielding a 
risk-haplotype from D21S11920 till the telomeric end. In addition to 
the patients parts or the entire risk haplotype was also present in 3 
at risk individuals.
Discussion
To our knowledge, this is the first report on genetic analysis of a 
family with adult NCL, with a pedigree which suggests autosomal 
dominant inheritance. Although this study was unable to identify a 
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single genetic defect, three haplotypes were identified which 
segregate with the disease. However, conclusions are hampered by 
segregation with some unaffected family members. The study is 
limited by the small number of affected family members, and also by 
lack of predictive information in unaffected individuals. Although we 
showed that an abnormal electroencephalogram in an asymptomatic 
family member could be predictive of disease 11 , it was not applied in 
this study because of ethical reasons. 
Because of small family size, relatively low LOD scores were expected 
and obtained from the initial genome-wide STR-based linkage 
analysis. We used an approach where (from the 8 loci suggestive for 
linkage with a LOD-score > 1, in an autosomal dominant model) only 
3 loci were selected for detailed analysis by genotyping additional 
STR markers in the region: the locus with the highest multipoint LOD 
score of 1.73 on chr. 12, and two other loci (on chr. 2 and chr. 21, 
where two subsequent markers gave a LOD-score above 1 ). The 
current findings are therefore insufficient to exclude genetic loci apart 
from our 3 investigated loci. 
It is unlikely that known genetic loci for NCL contribute to the 
etiology of our family, since markers in the proximity of the known 
NCL loci (1p32, 11p15, 16p12.1, 13q21, 15q21-33, 8p23, 11p15.5) 
were checked, while none passed a LOD-score value of 1. 
Furthermore, PPT activity was normal in patients of our family 10, 
which excludes CLN1. GRODs are present in our patients, but are 
uncommon in NCL forms other than CLN1. 
Besides , our pathological and clinical findings were very similar to 
other reported AD-ANCL families, which suggests a nosological entity. 
AD-ANCL is also distinct from other ANCL forms because of its 
dominant inheritance. It is intriguing that all other NCL forms show 
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an autosomal recessive mode of inheritance. Dominant occurrence at 
young age of a devastating disease like NCL would most likely have a 
very negative effect on the chance of reproductive offspring. 
While 8 genes are identified in childhood NCL3, knowledge on the 
genetic basis of adult NCL is very limited. Our study did not identify a 
single gene. However, our limited findings may contribute because 
genetic knowledge on ANCL is so far completely lacking. 
Some individual cases with adult presentation of one of the childhood 
NCL forms have been reported. For example, two sisters with 
neuronal ceroid lipofuscinosis presenting in the fourth decade had a 
profound deficiency of PPT related to the CLN1 gene mutation R151X 
and a novel missense mutation G108R12. Another ANCL patient was 
reported, who also was a compound heterozygote with mutation 
R151X, but here the other mutation was a novel mutation, 
p.Cys45Tyr, which probably disrupts one of two hydrogen bonds with 
Asp79,6 causing a less severe structural defect. Enzyme activity of 
PPT1 was diminished but not abolished13. PPT activity was normal in 
patients of our family 10. 
Sleat et al identified CLN5 as a cause in an ANCL patient, using an 
innovative proteomic approach, using the presumption that lysosomal 
storage diseases arise from mutations in genes encoding lysosomal 
proteins that contain mannose 6-phosphate, a carbohydrate 
modification that acts as a signal for intracellular targeting to the 
lysosome. Purification and quantification of mannose 6-
phosphorylated proteins by affinity chromatography in 23 patients 
with confirmed or possible lysosomal disease, identified or validated 
the genetic basis for disease in 8 cases14. In one ANCL patient 
[CABM-BR19], this method indicated loss of CLN5, which confirmed 
previously identified but unreported missense changes (377G>A 
(Cys126Tyr) and 1121A>G (Tyr374Cys)). 
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This group also found an unusual cause in a patient suspected of 
ANCL (HSB#4165), where this chromatographic method indicated 
absence of SGSH, which is a lysosomal enzyme that is defective in 
MPSIIIA, a disorder unrelated to the NCLs. Sequence analysis 
indicated compound heterozygosity for two missense mutations, 
Glu355Lys and Ser298Pro in SGSH, both of which are documented 
pathogenic alleles in MPSIIIA. While clinical details and ultrastructure 
were not reported in this case, it is unclear whether this case fulfills 
diagnostic criteria for ANCL, which has often led to misdiagnosis 15. 
This proteomic approach directed towards study of lysosomal 
enzymes could also be useful in future studies of AD-ANCL. A 
different approach for further research could be genetic linkage study 
of multiple families with presumed identical autosomal dominant 
disease, with similar clinical presentation and ultrastructure. This is 
now the focus of the Rare NCL Gene Consortium (RNGC), which was 




Table 1 : 8cM density genome-wide scan, showing 2-point LOD-scores $ 
1 for 10 STR markers in 8 distinct chromosomal regions
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Table 2: genotyping on chromosome 12 using 22 additional STR 
markers, covering 25 MB, where LOD score calculations achieved a new 
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Objective: To describe the findings in 59 EEGs from six patients from 
three generations in a family with autosomal dominant adult neuronal 
ceroid lipofuscinosis (Parry disease), autopsy proven, with a follow up of 
9–21 years. 
Methods: Descriptive, visual EEG analysis. 
Results: In these patients with epilepsy, myoclonus, dementia and 
Parkinsonism, EEGs were all severely abnormal, with generalized or 
bilateral independent periodic epileptiform discharges the most common 
pattern. In a few EEGs periodic discharges were seen. No alpha rhythm 
was present. No paroxysmal response to photic stimulation was seen. 
Intraindividual EEG changes in the course of the disease were modest, 
despite severe clinical disease progression. No cortical component linked 
to myoclonus could be found with a backaveraging technique. 
Conclusion:EEG in autosomal dominant neuronal ceroid lipofuscinosis is 
dominated by generalised periodic epileptiform discharges (GPEDs, or 
GPD+).
Significance: GPD/GPEDs in adults with myoclonus, Parkinsonism, 
dementia or epilepsy should raise the possibility of adult neuronal ceroid 




Electroencephalography (EEG) is very helpful in the diagnosis of 
epilepsy, sleep disorders, herpes encephalitis, Creutzfeldt–Jakob disease 
(CJD) and subacute sclerosing panencephalitis (SSPE), where patterns 
can be very specific. Kurlemann and Schuierer (1994) emphasized the 
occurrence of several other specific EEG patterns in neurological 
disorders of childhood, including positive spikes during low frequency 
photostimulation for late infantile neuronal ceroid lipofuscinosis(LINCL). 
Neuronal ceroid lipofuscinosis(NCL, Batten disease)is a group of genetic 
disorders with intraneuronal lysosomal storage of autofluorescent 
lipopigment, leading to blindness, myoclonus, epilepsy, cognitive and 
motor dysfunction. Classically they were categorized according to age of 
onset: infantile(INCL), late infantile(LINCL), juvenile(JNCL) and adult 
(ANCL). Now 8 forms are distinguished (CLN1–8), while five genes have 
been isolated and characterized (CLN1, 2, 3, 5&8)(Mole, 1999, 2004). 
EEG has been shown to provide several more or less specific patterns in 
the different childhood neuronal ceroid lipofuscinosis (NCL) forms. 
Absence of sleep spindles occurs in Infantile NCL (INCL), even while ERG 
and VEP are still normal (Santavuori et al., 1992). Vanhanen et al. 
(1997) indicated that although the EEG may be normal at the preclinical 
stage, electroencephalography is the first electrodiagnostic examination 
to reveal abnormalities in INCL, showing an attenuated reaction to 
passive eye opening and closing, followed by disturbances in background 
activity, diminution in amplitude and disappearance of sleep spindles. In 
later stages, slowing or attenuation of EEG to inactivity is seen. All 
neurophysiologic reactions are abolished by the age of 4 years. No 




In late infantile NCL the electroencephalogram may show high 
amplitude, irregular delta–theta activity and spike-or polyspike-wave 
discharges (without localized preponderance) and grossly enlarged 
responses to single light flashes. Spikes in response to intermittent low 
frequency(<3Hz) photostimulation appear by the age of 7–8 years and 
disappear after 11 years of age. Increased slowing and decreased 
amplitude is seen in the course of the disease (Binelli et al., 2000). In 
variant LINCL, electrophysiological abnormalities on EEG, ERG and VEP 
are similar as described in the classical LINCL (Wisniewski et al., 1993). 
In juvenile NCL (JNCL) Lagenstein et al. reported 2.5–3.5 Hz slow-spike-
waves, meeting the criteria of the Lennox syndrome (Lagenstein et al., 
1978). Runs of slow spikes and waves are often seen, (Sainio, 1997; 
Williams et al., 1999) but EEG findings are less specific than in most 
other NCLs. Adult NCL is rare, with onset around the age of 30, leading 
to myoclonus, epilepsy, Parkinsonism, dementia or ataxia. Visual 
symptoms are uncommon, unlike in childhood forms. Knowledge of adult 
NCL forms develops slowly, compared to the major advances in 
childhood NCL in the last 15 years. Most adult NCL reports indicate 
autosomal recessive inheritance, known as Kufs’ disease. Berkovic et al. 
(1988) reviewed 118 cases of autosomal recessive ANCL. They 
concluded that in this recessive form of the disease, EEG is less specific, 
showing diffuse slowing, or generalized spike-wave discharges (in a so-
called type A phenotype). As in LINCL, an intense photoparoxysmal 
response may occur, especially to low-frequent flashes of 1–2Hz 
(Vadlamudi et al., 2003). 
Here we report on EEG findings in a family with the extremely rare 
autosomal dominant form of adult neuronal ceroid lipofuscinosis, called 
Parry disease. Detailed clinical and autopsy findings of this family have 




This observational study describes visual EEG analysis of 59 EEG 
recordings in six patients, in three generations of a family with 
autosomal dominant adult neuronal ceroid lipofuscinosis. The diagnosis 
was confirmed with electronmicroscopy in two autopsies, where massive 
intraneuronal storage was seen throughout the brain, mainly consisting 
of granular osmiophilic deposits (GRODs)(Nijssen et al., 2003). Twenty-
four EEGs were digitally recorded, 35 on paper, from Ag/AgCl surface 
electrodes, using the international 10–20 system, with a timebase of 
30mm/s, RC=1.2s, gain 70 µV/cm. All EEGs were recorded while awake, 
with eyes open and closed. 
Results
Patient 1 
This woman with generalized tonic clonic seizures from the age of 44 
years, had progressive cognitive decline, myoclonus and Parkinsonism, 
leading to death at the age of 51. Her medical records report a severely 
disturbed EEG at the age of 45 years, with frequent intermittent 
epileptiform bursts; the recording could not be retrieved.
Patient 2 
This woman is a daughter of patient 1. She had myoclonus of arms and 
face from the age of 46 years, followed by progressive dementia, 
Parkinsonism, generalized tonic clonic seizures and psychotic episodes. 
She died at the age of 59 years. Thirteen EEGs were recorded, from the 
age of 45 until 54. The first EEG showed normal backgroundactivity, with 
frequent generalized bursts of slow waves mixed with spikes. While 
burst activity remained similar, spike activity increased in the course of 
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the disease: in the last years runs of spikes dominated, eventually with 
very long trains of bilaterally synchronous spikes. 
Patient 3
This sister of patient 2 had several depressive episodes, and developed 
generalized epileptic seizures at the age of 42 years, followed by 
psychotic episodes, Parkinsonism, myoclonus and progressive dementia. 
She died at the age of 56 years. Five EEGs were recorded, from the age 
of 45 until 52. Compared to her sister, these EEGs had almost twice as 
many bursts, of shorter duration. Spikes were less frequent, and except 
for some duplets in complexes, isolated polyspikes were not seen. Her 
last EEG showed continuous bilaterally synchronous delta activity of 
around 1 Hz, amplitude 10 µV. 
Patient 4 
This brother of patients 2 and 3 had myoclonic jerks of the arms since 
the age of 36 years. Progressive memory impairment, depressive 
episodes and visual hallucinations, Parkinsonism and generalized tonic 
clonic epileptic insults led to severe disability, he died at the age of 56 
years old. Ten EEGs were recorded, from the age of 40 until 55. As in his 
sisters, the EEGs showed bilaterally synchronous epileptiform 
discharges, of intermediate frequency and duration compared to his 
sisters’. Here also, the number of isolated spikes increased during the 
years. One postictal tracing showed continuous bilaterally synchronous 
highvoltaged (300µV) 1.5–2 Hz delta activity. A week later –after 
treatment with phenytoin– the EEG was as before. During a period with 
overt myoclonus, an EEG was recorded with backaveraging, using the 




This daughter of patient 2 had tension-type headache and migraine 
attacks without aura from the age of 19 years. Neurological examination 
at the age of 24 years was normal. During her first pregnancy, at the 
age of 32, she developed myoclonus of the right arm. Since delivery, 
progressive myoclonus in both arms and chin occurred. She has slight 
memory difficulties and dysarthria. She had a generalized tonic clonic 
seizure after delivery of her second child. Ten EEGs were recorded, from 
the age of 24 until 45. Despite lack of symptoms and signs at the age of 
24, by then an EEG showed bilaterally synchronous epileptiform 
discharges, morphologically similar to those in affected family members, 
but with very few spikes, and no polyspikes. The number of spikes 
fluctuated in the course of the disease; no isolated spikes were seen 
(Fig. 1).
Patient 6 
In the son of patient 4, 21 EEGs were recorded, from the age of 25 until 
43. He has had myoclonus of the thumb and arms from the age of 25. 
At that time, an EEG showed bilaterally synchronous epileptiform bursts. 
At the age of 31 he experienced attacks with loss of consciousness for 
several seconds. Two years later he had a generalized tonic clonic 
seizure after heavy alcohol consumption, followed by frequent 
generalized seizures. His EEGs show relatively short bursts, with a few 
low voltaged spikes interspersed in the high voltaged complexes, but no 
isolated spikes(Figs. 2 and 3). 
Features common to all EEG recordings 
The epileptiform bursts were often bilaterally synchronous, with GPEDs 
(generalized periodic epileptiform discharges, now called GPD), 
sometimes also more bilaterally independent. Although burst length was 
variable, they were often of similar morphology, but never identical. 
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Also, the length of interburst intervals was never predictable, but 
patients with longer discharges often also had longer intervals. No 
response to photostimulation was seen in any EEG with either single 
flash, low or high frequency stimulation. No alpha rhythm was seen in 
any of the tracings, although a response to eye opening and closing was 
sometimes clear (altered burst frequency, or runs of highvoltaged delta). 
The background activity in intervals between bursts consisted of an 
irregular mix of beta and alpha activity with some theta.
Discussion 
Autosomal dominant adult NCL (‘Parry disease’) is an extremely rare 
disorder: only a few families have been reported (Boehme et al., 1971, 
1980; Josephson et al., 2001; Nijssen et al., 2002, 2003; Brodner et al., 
1976; Ferrer et al., 1980; Arpa et al., 1991). EEG findings in our family 
are very similar to those reported in the Parry family as described by 
Boehme et al. (1971): in their patient IV/2‘... an EEG was grossly 
abnormal, showing long runs of slow waves in the 0–4 and 4–7 cps 
range, preceded by spikes and sharp waves. ...bilaterally diffuse and 
synchronous...’. In patient IV/3 ‘several EEGs revealed an atypical spike 
and wave pattern which was bilaterally symmetrical and superimposed 
on a slow background rhythm with a predominance of 3–5 cps’. In 
patient IV/5 ‘the waking EEG showed a dominant activity of 10–11 cps, 
interspersed with general slowing. When drowsy, frequent bursts of 
bilateral rhythmic slowing with 2–3 cps appeared. Simultaneously 
paroxysms of high voltaged spikes developed with atypical spike-slow 
wave complexes, usually seen in both hemispheres synchronously’. In 
patient IV/15 ‘an EEG showed frequent generalized paroxysms of 
highvoltaged rhythmic slowing, sharp waves, and occasional spikes, 
suggestive of a ‘‘burst-suppression pattern” ’. Besides, the 
electronmicroscopical and clinical findings in their family are also very 
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similar. These findings strongly suggest that their and our family suffer 
from a single disease. The evidently pathological EEG findings in patient 
5 at the age of 24 years old, while she was clinically asymptomatic 
(except for migraine with aura, which is most likely unrelated to the 
NCL), suggests that the EEG could be used as a screening tool in 
asymptomatic patients. If the EEG shows abnormalities similar to those 
described above, in an asymptomatic member of a family with 
autosomal dominant NCL,this probably indicates that this person is 
affected, and will develop symptoms later on. The negative predictive 
value or sensitivity of the EEG cannot be determined from this 
observation. In the single case of a family with autosomal dominant 
adult NCL described by Ferrer et al. (1980), the EEG was normal. In a 
single case reported by Brodner et al. (1976) the EEG was normal in an 
individual with biopsy–proven NCL from a family with autosomal 
dominant NCL described previously by Boehme et al. (1971). The 
diagnosis was made during surgery for an astrocytoma at the age of 24, 
while disease onset in other affected familymembers was usually at the 
age of 31. Similarly, normal EEGs have been reported in patients with 
autosomal recessive Kufs disease. The sensitivity of the EEG as a 
screening test for adult NCL in asymptomatic individuals may thus be 
limited. Although a few EEGs in our family showed episodes with 
periodic discharges, the common epileptiform burst pattern showed 
large variation of the intervals between the complexes. The term 
’pseudoperiodic’, as suggested by Markand and Daly(1971) may be more 
indicative, but is not sharply defined. In many of our EEGs, spikes and 
polyspikes occurred in slowwave complexes with long intervals (max 
25s) resembling GPEDs (generalised periodic epileptiform discharges), 
or according to more recent nomenclature GPD’s (generalised periodic 
discharges) plus (Hirsch et al., 2005). 
Veneselli et al. (2001) reported on findings in 60 electroencephalograms 
in a group of 30 Italian childhood NCL cases. They observed 4 INCL, 18 
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LINCL (and variants) and 8 JNCL patients, with electronmicroscopic 
conformation of the diagnosis in all cases. In 3 of 4 INCL cases a 
‘vanishing’ (low voltage) EEG pattern was seen, a single INCL case had 
slowed background activity and atypical spikes and waves. In EEGs from 
18 LINCL patients they distinguished three different patterns:(A) slowed 
background activity and pseudoperiodic, atypical highvoltage slow spikes 
and waves, mostly in the posterior regions (15 of 18); (B) 
subcontinuous/continuous slow spike and wave activity( 2 of 18);(C) 
multifocal epileptiform abnormalities (single case). In 8 JNCL patients, 
they found normal background activity with runs of slow spikes and 
waves in 5; and slightly slowed background with frequent abnormalities 
resembling a pattern of generalized epilepsy. Vanishing EEG, as seen in 
the final stage of INCL was not seen in our family. However, no EEGs 
were obtained in the final 4 years of life of patients 2 and 3, which might 
have shown decreasing amplitude. However, no amplitude reduction 
occurred during the many years of follow up in our patients. Similar to 
the series of variant LINCL patients described by Veneselli, we found no 
correlation between the EEG characteristics and the stage of the 
disease, except for an increasing number of spikes with increasing age 
in patient 2. 
The consistent findings in this family with autosomal dominant adult NCL 
indicate that GPEDs in adults with myoclonus, Parkinsonism, dementia 
or epilepsy should raise suspicion of adult neuronal ceroid lipofuscinosis, 
especially with familial occurrence. 
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Fig. 1. Electroencephalogram of patient 5 at the age of 38 shows highvoltaged 
generalised epileptiform discharges of slow waves mixed with sharp waves. 
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Fig. 2. EEG of patient 6 at the age of 39 shows long bursts of generalized high 
amplitude slow waves mixed with spikes and sharp activity. 
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Fig. 3. EEG of patient 6 at the age of 41 shows bilaterally synchronous periodic 
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Objective: to investigate the occurrence of auditory dysfunction in a 
family with autosomal dominant adult neuronal ceroid lipofuscinosis 
(ANCL). 
Methods: descriptive
Results: Hearing impairment was common in our autosomal dominant 
ANCL family, which has 6 affected family members in three generations. 
In all 5 affected siblings who had Auditory Brainstem Responses, waves 
I to V were delayed, with progressive abnormalities in later disease 
stages. 
Conclusion: occurrence of progressive auditory dysfunction is very 
common in autosomal dominant ANCL, which has not been reported in 




Neuronal ceroid lipofuscinosis is a group of inherited lysosomal storage 
diseases with neurodegeneration characterized by storage of 
intraneuronal lipofuscin-like material1. Most forms have an autosomal 
recessive mode of inheritance2 and present at childhood with prominent 
visual loss, epilepsy, cognitive decline and movement disorders3. We 
study a family with a very rare form of neuronal ceroid lipofuscinosis 
(‘Parry disease’) which presents at adult age, and has an autosomal 
dominant inheritance pattern4, 5. Auditory symptoms are not a common 
feature of childhood NCL. We studied the occurrence of auditory 
dysfunction in autosomal dominant adult NCL (ANCL). 
Patients
Clinical records and clinical neurophysiological records of 6 affected 
members of a reported family with autosomal dominant ANCL (fig 1: 
family pedigree) which was proved by autopsies5, were retrospectively 
reviewed for auditory symptoms and brainstem auditory evoked 
potential recordings. A short description of clinical symptoms and signs 
is given for each patient.
Patient 1 
She had tonic clonic seizures from the age of 44 years, progressive 
dementia, myoclonus and parkinsonism. She complained of slowly 
progressive hearing impairment since the start of other symptoms at 
age of 44. She died at the age of 51. 
Patient 2
This daughter of patient 1 had myoclonus of arms and face from the age  
of 46 years, followed by progressive dementia, parkinsonism, 
generalized tonic clonic seizures and psychotic episodes. She reported 
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progressive hearing impairment at the age of 46. By then, moderate to 
severe hearing difficulty was reported by a psychologist in a 
neuropsychological test report. Auditory Brainstem Responses (ABR) 
recorded at age 47 showed a severely disturbed pattern of hardly 
distinguishable responses. A year later only a wave V was discernible in 
the right ABR, while at the left all waves (including wave I) were 
severely delayed. The last ABR at age 51 showed only a severely 
delayed wave V (latency 5 SD at the right, 2.5 SD at the left). She died 
at the age of 59 years.
Patient 3 
This sister of patient 2 had depressive episodes, and developed 
generalized epileptic seizures at the age of 42 years, followed by 
psychosis, parkinsonism, myoclonus and progressive dementia. She died 
at the age of 56. She had hearing difficulty of the left ear from the age 
of 24, and both vertigo and tinnitus from age 27. She had severe 
bilateral perception deafness requiring hearing aids on both sides from 
the age of 40.
ABR showed only cochlear microphonics and a delayed wave I (1,92 ms) 
at the age of 45, while several ABR between age 46 and 48 showed no 
waves at all.
Patient 4 
This brother of patients 2 and 3 had myoclonic jerks of the arms since 
the age of 36 years. Progressive memory impairment, depressive 
episodes and visual hallucinations, parkinsonism and generalized tonic 
clonic epileptic insults led to severe disability, he died at the age of 56 
years. He had moderate hearing difficulty. ABR at the age of 48 showed 
cochlear microphonics only at the left, with hardly discernible delayed 
waves IV and V at the right. A year later hearing threshold was 40 dB. 
With 103 dB stimulation at the right ear, cochlear microphonics were 
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seen, but no wave I or II, while wave III had a latency of 5 ms; latency 
of wave V was 6.5 ms (contralaterally 6,6 ms). At the left a similar 
pattern was seen but without cochlear microphonics (III en V latencies 
of 5.3 and 6.8 ms). Electronystagmography at the age of 54 showed no 
caloric response on both sides (30 and 44C).
Patient 5 
This daughter of patient 2 had migraine attacks without aura from the 
age of 19 years. Neurological examination at the age of 24 years was 
normal. During pregnancy at the age of 32, she had myoclonus of the 
right arm. She has progressive memory difficulties and generalized tonic 
clonic seizures. She has had six ABR ‘s between the age of 24 and 41 
years old (fig 2), with progressively increasing latencies. ABR at the age 
of 38 showed no abnormalities except for a delay of wave I latency at 
the right side. 
Patient 6
This son of patient 4 has had myoclonus of the thumb and arms from 
the age of 25. From the age of 31 he has epilepsy, parkinsonism, 
polyminimyoclonus and visual dysfunction. He has had eight ABR’s 
between age 25 and 38, which show increasing latencies of all waves 
with increasing age, but less severe than patient 5(fig 2).
Conclusions
The large NCL literature has only a few reports on auditory symptoms: 
auditory hallucinations6 were reported in a single Late Infantile NCL 
(LINCL) case; impaired auditory attention7, and decreased auditory 
memory span8 were observed in Juvenile NCL (JNCL). 
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ABR has been studied scarcely in NCL, with normal responses in a case 
of JNCL9 and a case of LINCL10, while ABR was enhanced in a case of 
LINCL11. Abnormal brainstem auditory evoked potentials were found in 
35% of individuals with Northern epilepsy12.
We have previously reported storage of lipofuscin and 
neurodegeneration in the brainstem of patients 2 and 3 5, which may 
explain the progressively abnormal late ABR waves, but the obvious 
delay of early ABR waves indicates co-occurrence of peripheral 
pathology. This has not been previously reported in adult NCL, but in 
JNCL, Elleder et al 13 studied inner ear cells, showing ultrastructural 
intralysosomal curvilinear and fingerprint patterns in several cell types 
including the receptor cells of the organ of Corti and sensory cells of 
crista ampullaris. We hypothesize a similar mechanism in autosomal 
dominant ANCL. This is supported by absent caloric 
electronystagmography responses in patient 4.
Our study indicates that in contrast to other NCL forms, auditory 
dysfunction and abnormal Auditory Brainstem Evoked Responses are a 
common feature of autosomal dominant adult NCL. Unlike EEG14 , ABR 
seems to be progressively abnormal in later disease stages. 
Fig 1. Family pedigree
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Fig 2. ABR latencies of waves I-V versus age (top panels: patient 5 (right/left), 
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Objective: to study visual problems in six patients from three 
generations of a family with autosomal dominant adult neuronal ceroid 
lipofuscinosis (AD-ANCL). 
Methods: We surveyed their records for any data related to vision.
Results: In five patients visual dysfunction was obvious, with both 
positive visual symptoms (sometimes in temporal relation with epileptic 
attacks) and decreased visual acuity with abnormal VEP and ERG. Bull’s 
eye maculopathy was seen in one patient, who also had a hyperintense 
lesion of the optic radiation on MRI. 
Conclusion: visual problems are common in AD-ANCL, due to retinal 
pathology, optic nerve atrophy, optic radiation degeneration, cortical 




Progressive loss of vision leading to blindness is one of the major 
manifestations in childhood forms of neuronal ceroid lipofuscinosis 
(NCL), which show recessive inheritance. 
Adult NCL has a rare recessive form (Kufs’ disease), and a very rare 
autosomal dominant form (Parry disease). Ophthalmological findings in 
recessive adult NCL are reported to be normal{Berkovic et al., 1988, 
Brain, 111 , 27-62}, in sharp contrast to childhood forms. Here we 
report on visual problems in a family with the autosomal dominant adult 
form of NCL (AD-ANCL). 
Methods
Descriptive and retrospective. We have carefully screened all medical 
records of our six patients from a known family with AD-ANCL {Nijssen 
et al., 2002, Mov Disord, 17, 482-7} for any clinical, neurophysiological, 
ophthalmological, and imaging data related to vision. Diagnosis was 
confirmed by electronmicroscopy as described previously {Nijssen et al., 
2003, Brain Pathol, 13, 574-81}. The cases will be described briefly.
Results
Patient 1 
This woman with tonic clonic seizures from the age of 44 years, had 
progressive cognitive decline, myoclonus and parkinsonism. She died at 
the age of 51. 




This woman is a daughter of patient 1. She had myoclonus of arms and 
face from the age of 46 years, followed by progressive dementia, 
parkinsonism, tonic clonic seizures and psychotic episodes. She died at 
the age of 59 years. At the age of 46 years old, she mentioned flashes 
in both eyes. Several months later she described seeing all kinds of 
colors. No other visual symptoms could be found in her extensive 
medical records. Neuropsychological testing showed severe difficulties in 
a trail making test and also in copying complex figures, but no visual 
problem were reported. 
Visual evoked potential (VEP) at the age of 46 years old showed a P100 
latency of 115 ms on both sides (normal <117 ms). Two VEP’s in the 
next 2 years were similar. 
Patient 3 
This sister of patient 2 had depressive and psychotic episodes, epileptic 
seizures, parkinsonism, myoclonus and dementia. She died at the age of 
56. 
At the age of 47 she mentioned seeing flashes frequently. A year later 
she reported colorful optic sensations, which were hard to describe in 
more detail. In the next two years she complained of blurred vision, and 
progressively decreasing visual acuity. 
VEP at the age of 48 showed delayed P100 latencies of 136 and 146 ms. 
Four years later VEP showed no discernable responses anymore.
Patient 4 
This brother of patients 2 and 3 had myoclonic jerks of the arms since 
the age of 36 years. He had progressive memory impairment, 
depressive episodes, parkinsonism, facial dyskinesias and tonic clonic 
epileptic insults. He died at the age of 56 years. 
AD-ANCL visual
125
He mentioned seeing stars and black patches at the age of 43. Five 
years later a tonic clonic epileptic seizure had a prodrome consisting of 
seeing stars. In the last months of his life he had an episode with visual 
hallucinations of persons.
Electronystagmography at the age of 54 showed saccadic pursuit 
movements, hypometric and overshoot saccades and absent caloric 
responses (indicating peripheral as well as central vestibular 
dysfunction). Electrooculography and electroretinography at the age of 
54 showed a low normal Lp/Dt ratio, low scotopic amplitudes, while 
photopic responses were normal, indicating rod-dysfunction. At the age 
of 61 findings were similar. VEP at the age of 53 showed a delayed P100 
of 145 ms at the right side, and no response at the left.
Patient 5
This daughter of patient 2 had tension-type headache and migraine 
attacks without aura from the age of 19 years. Neurological examination 
at the age of 24 years was normal. Since the age of 32, she has had 
progressive myoclonus and slight memory difficulties. 
Since the age of 37 she had frequent attacks of colorful visual 
sensations, which were described as caleidoscopic speckles in the whole 
visual field, without impairing vision. The sensations were often the first 
symptoms of an epileptic attack with loss of consciousness. She saw 
hundreds of yellow or orange dots in a week of not taking her 
antiepileptic drugs. During a psychotic episode she saw spiders and 
magicians. She had several short attacks seeing indefinable colorful 
objects, which diminished after addition of levetiracetam. Since the age 
of 45 she complains of progressively worsening visual acuity, which 
decreased to 0.7 vs 0.5 at age 46. Fluorescein fundus angiogram 
showed slightly altered macular pigment distribution, but no Bulls eye 




This son of patient 4 has had myoclonus of the thumb and arms from 
the age of 25, and frequent tonic clonic seizures since age 31. 
Pattern VEP at the age of 31 showed delayed P100 latencies of 132 ms 
(right) and 134 ms (left). Six years later responses were extremely 
delayed (239 and 242 ms).
At the age of 38 he reported blurred vision, when visual acuity of the 
right eye was 3/6, 1/30 at the left. He then had attacks for 10 minutes, 
three times a week, seeing colorful images. A year later he reported an 
attack where he saw images of melting snow, blue patches, lots of hair, 
greyish faces, and a parade of people passing by. Visual acuity was 0.1 
vs 0.16. Fluorescein fundus angiogram showed a Bull’s eye maculopathy 
(fig. 2). Cerebral MRI showed optic nerve atrophy, and paraventricular 
T2 hyperintensity, extending in a thin line (cross-secting a plane parallel 
to the lateral ventricle wall) into the optic radiation (fig. 3). Later he had 
several attacks with images of hundreds of black hairs randomly 
scattered like mikado sticks on a white background, stripes in different 
colors, or more complex images like dolphins in an aquarium. After 
levetiracetam was added to his anti-epileptic drug regimen, positive 
visual sensations vanished. At age 44 visual acuity had decreased to 
0.05 vs 0.01. 
Optical coherence tomography (OCT) (fig 4A) showed severe retinal 
abnormalities, consisting of an atrophic retina on an intact Bruch 
membrane, with disturbed retinal layer morphology, merely due to 
thinning of the outer nuclear layer and outer segment layer (along with 
its hyperintense borders), and maybe also retinal pigment epithelium 
atrophy. Where the outer segment layer and retinal pigment epithelium 
were expected, granular bead-like structures were seen with a diameter 




Visual dysfunction is a hallmark of most NCL forms, but not in Kufs’ 
disease. 
In Infantile NCL (CLN1) visual symptoms occur in the first 2 years 
{Wisniewski et al., 1988, Am J Med Genet Suppl, 5, 27-46}, with retina 
degeneration, involution of retinal vessels, brownish macula 
discoloration and optic atrophy. VEP amplitudes decrease from the age 
of 2.5 years old, and extinction of VEP and Electroretinography (ERG) 
occur before the age of 4 years{Vanhanen et al., 1997, Dev Med Child 
Neurol, 39, 456-63}.
In classic Late Infantile NCL (CLN2) onset between age 2 and 4 
progresses to blindness at the age of 5 or 6 years old, with retina 
atrophy and centrifugally progressive loss of photoreceptors. ERG is 
diminished early, and finally extinguishes. Giant VEP (with amplitudes of 
around 350 V) is persistent, only to diminish in a preterminal stage 
{Pampiglione and Harden, 1977, J Neurol Neurosurg Psychiatry, 40, 
323-30}. 
In CLN3 visual failure presenting between 4 to 7 years old is often the 
presenting symptom, with rapid progression due to diffuse retinal 
pigment epithelium atrophy with stippled hyperfluorescence {Hainsworth 
et al., 2009, Retina, 29, 657-68} and optic nerve atrophy. Bull's eye 
maculopathy occurs in 1 in 4 {Hainsworth et al., 2009, Retina, 29, 
657-68}{Collins et al., 2006, Br J Ophthalmol, 90, 1119-24}. VEP shows 
markedly reduced amplitudes, and early extinction {Tackmann and 
Kuhlendahl, 1979, Eur Neurol, 18, 234-42} .
In CLN5 (Finnish v LINCL) giant VEPs are seen at 7-10 years of age 
{Lauronen et al., 2002, Clin Neurophysiol, 113, 1491-500}, while in 
CLN6 diminished or absent VEP were reported {Williams et al., 1999, 
The neuronal ceroid lipofuscinoses , 102 - 13}. In Northern epilepsy 
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visual evoked potentials were abnormal in 44% {Lang et al., 1997, Acta 
Neurol Scand, 95, 1-8}.
Despite evident retinal abnormalities in a member of our ANCL family 
and other NCL forms, some studies indicate that other factors than 
retinal pathology may contribute to visual deterioration in NCL. In a 
mouse PPT-1 gene knockout model progressive accumulation of 
autofluorescent storage material in all layers of the retina was observed, 
but only a modest loss of nucleated cells in the outer and inner nuclear 
layers. Retinal function was severely impaired by 8 months, despite only 
modest changes in retinal morphology {Lei et al., 2006, J Neurosci Res, 
84, 1139-49}. In Cln3(-/-) mice decreased optic nerve axonal density 
and decreased nerve conduction were found, with loss of neurons in the 
dorsal lateral geniculate nucleus (LGNd). Reduced transport of amino 
acids from the retina to the LGN suggested an impediment in 
communication between the retina and projection nuclei {Weimer et al., 
2006, Neurobiol Dis, 22, 284-93}. 
The granular bead-like structures with a diameter of 20 to 50 m which 
were seen on OCT in the outer segment layer and retinal pigment 
epithelium in patient 6 may represent degenerated retinal cells or 
clustered aggregates of storage material. It is not likely that these beads 
represent individual GRODs, since the size of ultrastructural granular 
osmiophilic deposits (GRODs) in CLN1 is usually up to 0.5 #m, forming 
aggregates of up to 5 #m {Elleder et al., 1999, The neuronal ceroid 
lipofuscinoses , 5-15}. GRODs found in neurons throughout the CNS in 
this family varied from 0.5 to 2.5 #m ø, while glial inclusions up to 4 #m 
ø were seen filled with numerous dense osmiophilic granules {Nijssen et 
al., 2003, Brain Pathol, 13, 574-81}. Early ultrastructural studies of the 
retina in human childhood NCL showed storage material in almost every 
type of retinal cells, loss of photoreceptors, atrophy of pigment 
epithelium and displacement of melanin into inner layers of the retina 
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{Goebel et al., 1974, Am J Ophthalmol, 77, 25-39} {Goebel, 1977, 
Fortschr Med, 95, 2432-6}.
In Kufs’ disease, the autosomal recessive adult NCL form, vision remains 
normal, and no retinal pigmentary degeneration occurs {Berkovic et al., 
1988, Am J Med Genet Suppl, 5, 105-9} {Berkovic et al., 1988, Brain, 
111 , 27-62}. A few case reports focus on the exceptions to this rule. 
Martin et al. reported storage in retinal ganglion cells in a single Kufs 
case {Martin et al., 1987, Clin Neuropathol, 6, 231-5}. Goebel et al. 
found granular lipopigment storage in nerve cells in different layers of 
the retina of a 33-year-old woman with biopsy-proven Kufs' disease who 
had never had visual impairment, nor electroretinographic abnormalities 
{Goebel et al., 1998, Acta Anat (Basel), 162, 127-32}. Ikeda et al. 
report a case of Kufs' disease with retinal lesions which resulted in total 
blindness, with retinal thinning with severe loss of rods, cones, and 
outer nuclear and outer plexiform layers. Ganglion cells of the retina 
were ballooned and contained lipopigments {Ikeda et al., 1984, Clin 
Neuropathol, 3, 237-9}. Armstrong et al. reported abnormal functioning 
of the amacrine and horizontal cell systems of lateral inhibition in a 
patient with Kufs’ disease {Armstrong et al., 1985, Int Ophthalmol, 8, 
37-42} {Dawson et al., 1985, Doc Ophthalmol, 60, 163-71}. Charles et 
al. found asymptomatic pigmentary retinal degeneration in a patient 
with questionable Kufs’ disease {Charles et al., 1990, Rev Neurol (Paris), 
146, 752-6}. Alonso-Navarra observed a single case of Kufs' disease 
with probable visual agnosia, hypermetamorphopsia {Alonso-Navarro et 
al., 2005, Rev Neurol, 40, 93-8}. Zini described a case of Kufs’ disease 
with focal occipital seizures with visual hallucinations where MRI showed 
cortical atrophy and, on T2-weighted images, hyperintensity and 
reduction of the deep white matter {Zini et al., 2008, Neurology, 71, 
1709-12}. However, according to Berkovic, the reported diagnosis of 
Kufs’ disease is often doubtful after critical reassessment (including 
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Dawson’s case) {Berkovic et al., 1988, Am J Med Genet Suppl, 5, 
105-9}{Berkovic et al., 1988, Brain, 111 , 27-62}.  In the autosomal 
dominant ANCL family described by Boehme, no sensory disturbances 
were seen, but their patient IV/2 presented with ‘a faint preceded by a 
visual aura of “bright spots” ‘{Boehme et al., 1971, Brain, 94, 745-60}. 
The single patient from an AD-ANCL family reported by Ferrer et al. had 
no reported visual problems{Ferrer et al., 1980, J Neurol, 222, 183-90}.  
In the AD-ANCL family described by Josephson et al. one patient had 
visuospatial deficits, one had ‘a spell with micropsia’ and visual 
hallucinations, in 3 others ophthalmologic examination was 
normal{Josephson et al., 2001, J Neurol Sci, 188, 51-60}. In the AD-
ANCL family from Alabama, 2 patients saw flashing lights as an aura to 
their seizures. None had optic atrophy or retinal degeneration on 
fundoscopic examination{Burneo et al., 2003, Epilepsia, 44, 841-6}. 
In our autosomal dominant ANCL family visual problems were frequent 
and diverse. Abnormal ERG’s and Bulls eye maculopathy indicate retinal 
pathology. Bilaterally delayed VEP’s may also indicate retinal, optic 
nerve, chiasma, tract or radiation dysfunction. Optic nerve atrophy was 
seen on MRI of patient 6, where cerebral MRI also showed optic 
radiation hyperintensity and atrophy of the visual cortex. 
Abundant positive visual signs in patient 3,4,5 and 6 were most likely of 
temporo-occipital epileptic origin, because of a temporal relation with 
epileptic seizures and response to anti-epileptic drugs. In patient 6 more 
complex images occurred in later stages with severely impaired vision, 
which may resemble Charles-Bonnet syndrome.  
The widespread visual pathology in this family with AD-ANCL is in 
contrast with the normal or minimal visual findings in Kufs’ disease. This 
supports our view that the autosomal dominant and the recessive form 








Fig. 3: T2 weighted cerebral MRI of patient 6, showing bilateral periventricular 
hyperintensity in the optic radiation (arrow).
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Fig. 4A: Optical coherence tomography (OCT) of patient 6. Retinal 
atrophy due to thinning of the outer nuclear layer and outer segment 
layer, and maybe also retinal pigment epithelium atrophy. Where the 
outer segment layer and retinal pigment epithelium were expected, 
granular bead-like structures were seen with a diameter of 20 to 50 m. 
4B: normal OCT and normal retinal histology 
(from http://vsri.ucdavis.edu , adapted from Optics ExpresNs, 2005; 
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Summary and concluding remarks
Although the Neuronal ceroid lipofuscinoses (NCLs) form the most 
common inherited progressive childhood encephalopathies, adult NCL is 
very uncommon. NCLs show recessive inheritance, except for the 
extremely uncommon autosomal dominant adult form (AD-ANCL, also 
called Parry disease). Only 6 families with AD-ANCL have been reported 
in detail. A Dutch family with the dominant adult NCL form is the subject 
of this thesis. 
In chapter 1 a review of the scarce literature on AD-ANCL is presented, 
and a brief review of the knowledge of childhood NCLs and recessive 
adult NCL (Kufs’ disease). The classification of NCL is explained, which 
has changed from age related categories to genotypes.
 
Chapter 2 presents clinical aspects of our family with adult neuronal 
ceroid lipofuscinosis with autosomal dominant inheritance. Detailed case 
reports of 6 affected individuals in three generations indicate disease 
onset in the fifth decade, with myoclonus in face and arms, epilepsy, 
auditory symptoms, cognitive decline, or depression. Parkinsonism 
occurred a few years after disease onset. The disease evolves to severe 
handicap, with severe dementia, contractures, dysphagia, and 
dysarthria. The pathophysiology of parkinsonian symptoms is treated in 
more detail in this chapter.
In chapter 3 we describe the neuropathological and biochemical autopsy 
findings in three patients with AD-ANCL. Throughout the brain abundant 
intraneuronal lysosomal storage of autofluorescent lipopigment granules 
was seen. Striking loss of neurons in the substantia nigra was found. In 
contrast, little neuronal cell loss occurred in other cerebral areas, 
despite massive neuronal inclusions. Visceral storage was present in gut, 
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liver, cardiomyocytes, skeletal muscle, and in the skin eccrine glands. 
The storage material showed highly variable immunoreactivity with 
antiserum against subunit c of mitochondrial ATP synthase, but uniform 
strong immunoreactivity for saposin D (sphingolipid activating protein 
D). Protein electrophoresis of isolated storage material revealed a major 
protein band of about 14 kDa, recognized in Western blotting by saposin 
D antiserum (but not subunit c of mitochondrial ATPase (SCMAS) 
antiserum). 
Electron microscopy showed ample intraneuronal granular osmiophilic 
deposits (GRODs), as occurs in CLN1 and congenital ovine NCL. These 
forms of NCL are caused by the deficiencies of palmitoyl protein 
thioesterase 1 and cathepsin D, respectively. However, activities of these 
enzymes were within normal range in our patients. Thus we propose 
that a gene distinct from the cathepsin D and CLN1-CLN8 genes is 
responsible for this autosomal dominant form of ANCL. 
In chapter 4 we tried to identify the genetic defect in our family with 
AD-ANCL. We applied genome wide STR-based linkage analysis with 
subsequent fine-mapping of candidate loci. Under an autosomal 
dominant model, 8 loci were suggestive for linkage with a LOD-score > 
1. Of these, three loci were most promising as two subsequent markers 
gave a LOD-score above 1 (on chr. 2 and chr. 21), while multipoint LOD-
score calculations achieved a maximum score of 1.96 on chr. 12. These 
3 loci were further analyzed by genotyping additional STR markers in 
the region. In the 3 loci a disease haplotype appeared to segregate with 
the disease. Markers in the proximity of the known NCL loci (1p32, 
11p15, 16p12.1, 13q21, 15q21-33, 8p23, 11p15.5) were checked but 
none passed a LOD-score value of 1.
In chapter 5 we describe the findings in 59 EEGs from six patients of our 
AD-ANCL familiy, with a follow up of 9–21 years. EEGs were all severely 
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abnormal, with generalized or bilateral independent periodic epileptiform 
discharges (GPEDs, or GPD+) as the most common pattern. In a few 
EEGs periodic discharges were seen. Intraindividual EEG changes in the 
course of the disease were modest, despite severe clinical disease 
progression. 
In chapter 6 we investigated the occurrence of auditory dysfunction in 
our family with AD-ANCL. Hearing impairment was common, and in all 5 
affected siblings who had Auditory Brainstem Responses, waves I to V 
were delayed, with progressive abnormalities in later disease stages. 
Auditory symptoms have not been reported in other NCL forms. 
In chapter 7 we studied visual problems in our family with AD-ANCL.
In five patients visual dysfunction was obvious. They had positive visual 
symptoms (some of which appeared to be related to epileptic attacks) 
and also decreased visual acuity, with abnormal VEP and ERG. Bull’s eye 
maculopathy was seen in one patient, who also had a hyperintense 
lesion of the optic radiation on MRI. His optical coherence tomogram 
showed retinal atrophy with granular lesions in retinal pigment 
epithelium. We conclude that visual problems are common in AD-ANCL, 
due to retinal pathology, optic nerve atrophy, optic radiation 
degeneration, cortical dysfunction or epilepsy. This finding is in contrast 
to general opinion which states that vision in adult NCL is normal. 
Future perspectives on the study of autosomal dominant ANCL are 
dominated by an itching desire to find the gene behind this disease, 
which could pave the road for genetic counseling, and ultimately even 
gene therapy. Because this is the only autosomal dominant NCL form, 
knowledge of this gene will most likely also expand insight into the 
pathogenesis of other NCL forms. Further exploration of the 
pathogenesis of this genetic neurodegenerative disease could also 
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provide insights which may help to understand diseases like Alzheimer 
and Parkinson’s. The clinical, pathological and neurophysiological 
similarity of reported and as yet unreported AD-ANCL families indicate 
an opportunity for genetic analysis by investigation of multiple families. 
This has led us to gather international efforts of genetic ANCL studies 
within the Rare NCL Gene Consortium (http://www.ucl.ac.uk/ncl/






Neuronale ceroid lipofuscinose (NCL) is een heterogene groep 
aandoeningen, waarbij stapelingsmateriaal in zenuwweefsel en netvlies 
gepaard gaat met blindheid, epilepsie, cognitieve achteruitgang en 
bewegingsstoornissen. NCL komt vooral voor op kinderleeftijd, en erft 
dan autosomaal recessief over. 
Dit proefschrift beschrijft een familie met een zeer zeldzame adulte NCL 
vorm met autosomaal dominante overerving (AD-ANCL). 
Hoofdstuk 1 beschrijft de literatuur over AD-ANCL, de diverse NCL 
vormen op kinderleeftijd en de classificatie van NCL. 
Hoofdstuk 2 beschrijft de kliniek van de familie met AD-ANCL die het 
onderwerp is van dit proefschift: bij zes personen uit drie generaties 
begon de ziekte meestal na het 40e levensjaar, met myoclonus 
(schokken) in gelaat en armen, epilepsie, gehoorsproblemen, cognitieve 
achteruitgang of depressie. Het verloop van de ziekte en de achtergrond 
van Parkinson-achtige klachten wordt beschreven. 
In hoofdstuk 3 worden neuropathologische en biochemische bevindingen 
in drie patienten met AD-ANCL beschreven. Een bijzonder 
stapelingsmateriaal (zogenaamde GRODs) dat kenmerkend is voor NCL 
werd aangetroffen in hersenen en in darm, lever, hart, spier en huid. In 
bepaalde regio’s van de hersenen (met name in de substantia nigra, die 
ook aangedaan is bij de ziekte van Parkinson) werd een verlies van 
zenuwcellen gezien. 
Stapelingsmateriaal bevatte subunit c van mitochondriaal ATP synthase 
en vooral saposine D (sphingolipide activerend proteïne D), twee 
eiwitten die ook in andere NCL vormen aangetroffen zijn. 
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In hoofdstuk 4 beschrijven we de resultaten van genetisch onderzoek 
naar de onderliggende genafwijking bij onze familie met AD-ANCL. 
Linkage analyse met STR-markers leverde 3 regio’s op op chromosoom 
2, 12 en 21 die bij alle patiënten met de ziekte aanwezig zijn. Dit 
onderzoek wijst er op dat de genen die verantwoordelijk zijn voor de 
kindervormen van NCL geen rol spelen bij deze familie. 
In hoofdstuk 5 worden bevindingen bij electroencephalografie (EEG, 
‘hersenfilmpje’) in deze familie beschreven, met patronen van sterk 
verstoorde electrische hersenactiviteit, zogenaamde gegeneraliseerde en 
bilateraal onafhankelijke periodieke epileptiforme ontladingen. Deze 
afwijkingen kunnen ook al optreden wanneer er nog geen symptomen 
van ziekte zijn. 
In hoofdstuk 6 beschrijven we gehoorsproblemen bij AD-ANCL, die 
aantoonbaar zijn met zogenaamde Auditory Brainstem Responses, die 
toenemende vertraging lieten zien met toenemende leeftijd. 
Gehoorproblemen zijn niet eerder beschreven bij NCL.
In hoofdstuk 7 beschrijven we visuele problemen in onze familie met 
AD-ANCL. Hoewel ANCL bekend staat om normale visus, werd bij 5 
patienten uit onze AD-ANCL familie een scala aan visusklachten gezien, 
met zowel verslechtering van het zien, als spontaan optredende visuele 
sensaties zoals het zien van kleurrijke flitsen. Dit was soms voorafgaand 
aan een epileptische aanval. Beelden van het netvies toonden een 
zogenaamde Bulls eye maculopathie. Recent ontwikkelde Optical 
Coherence Tomography toonde een beeld van retina atrofie en 
aanwezigheid van korrelige structuren in de pigmentlaag van het 
netvlies. Op MRI werden subtiele afwijkingen gezien in de 
occipitaalkwabben, in de radiatio optica. 
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Toekomstig onderzoek naar autosomaal dominante ANCL zal zich onder 
andere richten op voortzetting van de speurtocht naar het 
verantwoordelijke gen. Identificatie daarvan zal nieuwe mogelijkheden 
bieden voor genetische counseling en wellicht uiteindelijk zelfs voor 
gentherapie. Als de kennis van de pathofysiologie van deze ziekte 
toeneemt is het denkbaar dat ook het inzicht in de achtergrond van 
neurodegeneratieve ziektes zoals Alzheimer en Parkinson daardoor 
groeit. Inmiddels is een internationaal consortium in het leven geroepen 






ABR: Auditory Brainstem Responses 
AD-ANCL : autosomal dominant adult neuronal ceroid lipofuscinosis
ANCL: adult NCL 
CLN 1 to 8: NCL genes
CNS: central nervous system




EPMR: progressive epilepsy with mental retardation
FPs: fingerprint profiles
GRODs : granular osmiophilic deposits 
IBZM: iodobenzamide
INCL: infantile NCL
JNCL: juvenile NCL 
LAG1: longevity assurance gene 1.
LINCL : late-infantile NCL 
MFSD8: major facilitator superfamily domain containing 8 gene
MIM: Mendelian inheritance of man
MRI: magnetic resonance imaging
NCL: neuronal ceroid lipofuscinosis
OCT: optical coherence tomography 
PAS: periodic acid Schiff
PPT : palmitoyl protein thioesterase
SAPs : saposins
SCMAS : subunit c of mitochondrial ATPase
STR: short tandem repeat
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